<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"약물 계약" - Google 뉴스</title><link>https://news.google.com/search?pz=1&amp;cf=all&amp;hl=ko&amp;q=%EC%95%BD%EB%AC%BC+%EA%B3%84%EC%95%BD&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Thu, 18 Jun 2026 21:23:56 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>쿼드메디슨, 마이크로니들 기반 응급 약물 제조장비 계약 체결 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE1KdTR6NV91Ty1Xd0p4QnpTZ1RWcTlQS0phaDdvUVY4Tmo4RGVTU2NEc0JtbVdERWRRMjFmcm5fVHIzSFV4ZmVIdzlsZm9xR1NPZ0hoRQ?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE1KdTR6NV91Ty1Xd0p4QnpTZ1RWcTlQS0phaDdvUVY4Tmo4RGVTU2NEc0JtbVdERWRRMjFmcm5fVHIzSFV4ZmVIdzlsZm9xR1NPZ0hoRQ</guid><pubDate>Wed, 27 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE1KdTR6NV91Ty1Xd0p4QnpTZ1RWcTlQS0phaDdvUVY4Tmo4RGVTU2NEc0JtbVdERWRRMjFmcm5fVHIzSFV4ZmVIdzlsZm9xR1NPZ0hoRQ?oc=5" target="_blank"&gt;쿼드메디슨, 마이크로니들 기반 응급 약물 제조장비 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://m.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>알테오젠, 기술 이전 계약 다국적사 비공개→7년 만에 돌연 '사노피' 공개 - 뉴스맥</title><link>https://news.google.com/rss/articles/CBMiREFVX3lxTFAyYWxRdHJjWDJnUlJEYkF0MnR0alpmLUNXcmltU04xU2lQa3Zua09aTURrWVFVTlVnQ0NrZ1I3UUNFZTlO?oc=5</link><guid isPermaLink="false">CBMiREFVX3lxTFAyYWxRdHJjWDJnUlJEYkF0MnR0alpmLUNXcmltU04xU2lQa3Zua09aTURrWVFVTlVnQ0NrZ1I3UUNFZTlO</guid><pubDate>Wed, 17 Jun 2026 23:54:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiREFVX3lxTFAyYWxRdHJjWDJnUlJEYkF0MnR0alpmLUNXcmltU04xU2lQa3Zua09aTURrWVFVTlVnQ0NrZ1I3UUNFZTlO?oc=5" target="_blank"&gt;알테오젠, 기술 이전 계약 다국적사 비공개→7년 만에 돌연 '사노피' 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스맥&lt;/font&gt;</description><source url="http://www.newsmac.co.kr">뉴스맥</source></item><item><title>금지약물로 징계 받았던 케플러, 애리조나와 계약 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE4xTUJabENyTGpBQ3lsMXVMTEtTRFdnbGEteERqUzU1V09EcVI3ckx4ZmdFMFZyajZlb290RU1XQ2JmVzJhbHdUb2g5Y3ZsMkFVckQybA?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE4xTUJabENyTGpBQ3lsMXVMTEtTRFdnbGEteERqUzU1V09EcVI3ckx4ZmdFMFZyajZlb290RU1XQ2JmVzJhbHdUb2g5Y3ZsMkFVckQybA</guid><pubDate>Mon, 08 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE4xTUJabENyTGpBQ3lsMXVMTEtTRFdnbGEteERqUzU1V09EcVI3ckx4ZmdFMFZyajZlb290RU1XQ2JmVzJhbHdUb2g5Y3ZsMkFVckQybA?oc=5" target="_blank"&gt;금지약물로 징계 받았던 케플러, 애리조나와 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>쿼드메디슨, 한림제약과 응급 약물 제조장비 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE02cms1S1pqZGN5V0VyV3pMRE5qNk50WXEwMGstSUZBTTJrVEttNkE4QklfMlBGWGRvMmFNa0NVWU82eUY3QmcyMFVfdmRydGRiRHNaSnJuTUlJY1RORlp3TG1aZzFjbWRTMDhZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE02cms1S1pqZGN5V0VyV3pMRE5qNk50WXEwMGstSUZBTTJrVEttNkE4QklfMlBGWGRvMmFNa0NVWU82eUY3QmcyMFVfdmRydGRiRHNaSnJuTUlJY1RORlp3TG1aZzFjbWRTMDhZ</guid><pubDate>Fri, 15 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE02cms1S1pqZGN5V0VyV3pMRE5qNk50WXEwMGstSUZBTTJrVEttNkE4QklfMlBGWGRvMmFNa0NVWU82eUY3QmcyMFVfdmRydGRiRHNaSnJuTUlJY1RORlp3TG1aZzFjbWRTMDhZ?oc=5" target="_blank"&gt;쿼드메디슨, 한림제약과 응급 약물 제조장비 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>삼천당제약 "약물전달 플랫폼 'S-PASS' 특허권 100% 자사 소유" - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBwV09ZUXNnWE9xVkl3bFFVbS16R19qNHI1TE83SmVjczJzdjluRE9NSGJDQ01QTXZRVHdHUkNuMGNZOUVJNkp2eWF3S3BoUGZVNW5KRmVtX2M4UGd0aG1qbTVlbDNFNnJxRkx6dg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBwV09ZUXNnWE9xVkl3bFFVbS16R19qNHI1TE83SmVjczJzdjluRE9NSGJDQ01QTXZRVHdHUkNuMGNZOUVJNkp2eWF3S3BoUGZVNW5KRmVtX2M4UGd0aG1qbTVlbDNFNnJxRkx6dg</guid><pubDate>Wed, 08 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBwV09ZUXNnWE9xVkl3bFFVbS16R19qNHI1TE83SmVjczJzdjluRE9NSGJDQ01QTXZRVHdHUkNuMGNZOUVJNkp2eWF3S3BoUGZVNW5KRmVtX2M4UGd0aG1qbTVlbDNFNnJxRkx6dg?oc=5" target="_blank"&gt;삼천당제약 "약물전달 플랫폼 'S-PASS' 특허권 100% 자사 소유"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>아무리 급하다지만…'금지약물 징계 중인' 선수 계약, MLB 구단들 논란 예상 - mlbkor.com</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBhWTdwcVhWaW4ybHdsY3JFNU8zVFhvSVB3NThZUzVxUllZMGFtSXc2X3ZyajQwU0RETHdfWWpiTm9WeFJUa2Izb1d1cUhJckpqNG44d0lUYXlRaFI5cU1DN3BIS2x0Vnc?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTFBhWTdwcVhWaW4ybHdsY3JFNU8zVFhvSVB3NThZUzVxUllZMGFtSXc2X3ZyajQwU0RETHdfWWpiTm9WeFJUa2Izb1d1cUhJckpqNG44d0lUYXlRaFI5cU1DN3BIS2x0Vnc</guid><pubDate>Mon, 08 Jun 2026 05:34:01 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBhWTdwcVhWaW4ybHdsY3JFNU8zVFhvSVB3NThZUzVxUllZMGFtSXc2X3ZyajQwU0RETHdfWWpiTm9WeFJUa2Izb1d1cUhJckpqNG44d0lUYXlRaFI5cU1DN3BIS2x0Vnc?oc=5" target="_blank"&gt;아무리 급하다지만…'금지약물 징계 중인' 선수 계약, MLB 구단들 논란 예상&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;mlbkor.com&lt;/font&gt;</description><source url="https://www.mlbkor.com">mlbkor.com</source></item><item><title>"어차피 돈 나오는데…약물 할 만하네" 2년 연속 적발에 퇴출론까지, 선수들도 완전히 등돌렸다 - 조선일보</title><link>https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ19tS200NlduZmVxZVRpTmNPLUxTZmZWaEQ5VUhIcXNaTDFUUTlHLUxranpWMFJXN1dPQkFVVGQtQWpXLThHdUZvd3NyakhSeFdXTDJfUjg5aVE5dnUzZUs2aTBpbUk0bmtzMkxwWW1rWkVjMEFhUXhHSDg1bkJlYWMzeXVwTnc3OXJF?oc=5</link><guid isPermaLink="false">CBMiiwFBVV95cUxQQ19tS200NlduZmVxZVRpTmNPLUxTZmZWaEQ5VUhIcXNaTDFUUTlHLUxranpWMFJXN1dPQkFVVGQtQWpXLThHdUZvd3NyakhSeFdXTDJfUjg5aVE5dnUzZUs2aTBpbUk0bmtzMkxwWW1rWkVjMEFhUXhHSDg1bkJlYWMzeXVwTnc3OXJF</guid><pubDate>Sun, 08 Mar 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ19tS200NlduZmVxZVRpTmNPLUxTZmZWaEQ5VUhIcXNaTDFUUTlHLUxranpWMFJXN1dPQkFVVGQtQWpXLThHdUZvd3NyakhSeFdXTDJfUjg5aVE5dnUzZUs2aTBpbUk0bmtzMkxwWW1rWkVjMEFhUXhHSDg1bkJlYWMzeXVwTnc3OXJF?oc=5" target="_blank"&gt;"어차피 돈 나오는데…약물 할 만하네" 2년 연속 적발에 퇴출론까지, 선수들도 완전히 등돌렸다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;조선일보&lt;/font&gt;</description><source url="https://www.chosun.com">조선일보</source></item><item><title>할로자임, GSK와 'ADC SC’ 파트너십 딜..”ADC 첫계약” - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFAzb1lxVUh0b01BbjJjZExma29DX1JEYjhHSzQyeHNiTXd5Ry1FY25mZWdZeHBmUUVWN3l2U2N5WXhsMlJmNFV0TjA2a0JNcUpUYXNkSlBCVQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFAzb1lxVUh0b01BbjJjZExma29DX1JEYjhHSzQyeHNiTXd5Ry1FY25mZWdZeHBmUUVWN3l2U2N5WXhsMlJmNFV0TjA2a0JNcUpUYXNkSlBCVQ</guid><pubDate>Mon, 11 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFAzb1lxVUh0b01BbjJjZExma29DX1JEYjhHSzQyeHNiTXd5Ry1FY25mZWdZeHBmUUVWN3l2U2N5WXhsMlJmNFV0TjA2a0JNcUpUYXNkSlBCVQ?oc=5" target="_blank"&gt;할로자임, GSK와 'ADC SC’ 파트너십 딜..”ADC 첫계약”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>오가노이드사이언스, 한국생명공학연구원과 오가노이드 기반 기술도입 계약 체결 - 디지털투데이</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9KemdTa21rTE5KNDdkRkxnYXdBTzNQblY0RW13UDVOTHd3LTE3czBsb1d0c2dSVy1XMmNaVElxV25uRHR5T3Z4U0pmZTJKSTNweEN5ak16cmFWN1F3UmtzblAxbC1OSGhjWXZaZ0hTYW5yLWc?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9KemdTa21rTE5KNDdkRkxnYXdBTzNQblY0RW13UDVOTHd3LTE3czBsb1d0c2dSVy1XMmNaVElxV25uRHR5T3Z4U0pmZTJKSTNweEN5ak16cmFWN1F3UmtzblAxbC1OSGhjWXZaZ0hTYW5yLWc</guid><pubDate>Tue, 02 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9KemdTa21rTE5KNDdkRkxnYXdBTzNQblY0RW13UDVOTHd3LTE3czBsb1d0c2dSVy1XMmNaVElxV25uRHR5T3Z4U0pmZTJKSTNweEN5ak16cmFWN1F3UmtzblAxbC1OSGhjWXZaZ0hTYW5yLWc?oc=5" target="_blank"&gt;오가노이드사이언스, 한국생명공학연구원과 오가노이드 기반 기술도입 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;디지털투데이&lt;/font&gt;</description><source url="https://www.digitaltoday.co.kr">디지털투데이</source></item><item><title>한국비엔씨, 미국 'Leios'사 지방분해주사 약물 9개국 독점제조-판권 라이센싱 계약 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WU3hfWjdPMmR0ZGhPckRxbXBFVFRqQjBOSk1od19uNkVHUlE4VW1YSmtBbVRhT1ZhVkJwUjdOVHl6RVhlMEk4azlEOTI1ZURvLXZuOXhLMUpFOHpveGY4M3g5UGhIUQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE9WU3hfWjdPMmR0ZGhPckRxbXBFVFRqQjBOSk1od19uNkVHUlE4VW1YSmtBbVRhT1ZhVkJwUjdOVHl6RVhlMEk4azlEOTI1ZURvLXZuOXhLMUpFOHpveGY4M3g5UGhIUQ</guid><pubDate>Mon, 26 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WU3hfWjdPMmR0ZGhPckRxbXBFVFRqQjBOSk1od19uNkVHUlE4VW1YSmtBbVRhT1ZhVkJwUjdOVHl6RVhlMEk4azlEOTI1ZURvLXZuOXhLMUpFOHpveGY4M3g5UGhIUQ?oc=5" target="_blank"&gt;한국비엔씨, 미국 'Leios'사 지방분해주사 약물 9개국 독점제조-판권 라이센싱 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>노보, 단백질·펩타이드 경구화 기술 확보…먹는 비만약 시장 정조준 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE9RaG5FZXgtS3pIVjh0MWNZSXdlT1ZFM3FJTTB5TFpMa2VjUnNrak5LY3QxTUVpQjdibTgtbFNzYUhVQTN1NGEzQTI2amxrQXhvWC13Y28tSk1qbGl4TjF2cF9icV9FZXlONXFnRE1ndUlIZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE9RaG5FZXgtS3pIVjh0MWNZSXdlT1ZFM3FJTTB5TFpMa2VjUnNrak5LY3QxTUVpQjdibTgtbFNzYUhVQTN1NGEzQTI2amxrQXhvWC13Y28tSk1qbGl4TjF2cF9icV9FZXlONXFnRE1ndUlIZw</guid><pubDate>Thu, 26 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9RaG5FZXgtS3pIVjh0MWNZSXdlT1ZFM3FJTTB5TFpMa2VjUnNrak5LY3QxTUVpQjdibTgtbFNzYUhVQTN1NGEzQTI2amxrQXhvWC13Y28tSk1qbGl4TjF2cF9icV9FZXlONXFnRE1ndUlIZw?oc=5" target="_blank"&gt;노보, 단백질·펩타이드 경구화 기술 확보…먹는 비만약 시장 정조준&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>지투지바이오 "글로벌 A사와 깨진 것 아냐, 경쟁약물 잡을 후보물질 공동개발 협의 중" - 파이낸스스코프</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1RS3BZWmxuQUNrRk9ESjVJcG9CQ0pIV0RFeHlTOW00VDRrN0VsU2tGenFweVdQbnNodjdGeUFOOXVGQmJDRWRBek1VbkJxQjMtQjZWYmtZdHFNV2w2RjRCN2VOeThvUmtIenc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1RS3BZWmxuQUNrRk9ESjVJcG9CQ0pIV0RFeHlTOW00VDRrN0VsU2tGenFweVdQbnNodjdGeUFOOXVGQmJDRWRBek1VbkJxQjMtQjZWYmtZdHFNV2w2RjRCN2VOeThvUmtIenc</guid><pubDate>Mon, 16 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1RS3BZWmxuQUNrRk9ESjVJcG9CQ0pIV0RFeHlTOW00VDRrN0VsU2tGenFweVdQbnNodjdGeUFOOXVGQmJDRWRBek1VbkJxQjMtQjZWYmtZdHFNV2w2RjRCN2VOeThvUmtIenc?oc=5" target="_blank"&gt;지투지바이오 "글로벌 A사와 깨진 것 아냐, 경쟁약물 잡을 후보물질 공동개발 협의 중"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸스스코프&lt;/font&gt;</description><source url="https://www.finance-scope.com">파이낸스스코프</source></item><item><title>칸젠, 신테카바이오와 CDP 기반 AI 신약 공동개발 계약 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE95RUI3RjBEX3Z5M3RwbVVlZ3pjcEJ2WmtyczBVV0tuN2RnTHYxcWlIVnFySW1WMGJuN2pmM3hSMEczbXBhUldYbG5USmoyTEkzVlpwdW5IOWItcEszYW1XUWo1ODBUdnZfQVkyVmRR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE95RUI3RjBEX3Z5M3RwbVVlZ3pjcEJ2WmtyczBVV0tuN2RnTHYxcWlIVnFySW1WMGJuN2pmM3hSMEczbXBhUldYbG5USmoyTEkzVlpwdW5IOWItcEszYW1XUWo1ODBUdnZfQVkyVmRR</guid><pubDate>Fri, 19 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE95RUI3RjBEX3Z5M3RwbVVlZ3pjcEJ2WmtyczBVV0tuN2RnTHYxcWlIVnFySW1WMGJuN2pmM3hSMEczbXBhUldYbG5USmoyTEkzVlpwdW5IOWItcEszYW1XUWo1ODBUdnZfQVkyVmRR?oc=5" target="_blank"&gt;칸젠, 신테카바이오와 CDP 기반 AI 신약 공동개발 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>이엔셀, 인게니움과 'NK세포藥' 위탁생산 계약…미국 임상약물 추가 - 뉴스맥</title><link>https://news.google.com/rss/articles/CBMiREFVX3lxTFBkb2tiUmdpR1hIV2tYQkM3QkNBMTVFSHBqM05Fd0kxY2ViR1BQaUFoOWdMYWlZQjJkMGd4c1BRNEtCaGVF?oc=5</link><guid isPermaLink="false">CBMiREFVX3lxTFBkb2tiUmdpR1hIV2tYQkM3QkNBMTVFSHBqM05Fd0kxY2ViR1BQaUFoOWdMYWlZQjJkMGd4c1BRNEtCaGVF</guid><pubDate>Thu, 04 Jun 2026 01:23:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiREFVX3lxTFBkb2tiUmdpR1hIV2tYQkM3QkNBMTVFSHBqM05Fd0kxY2ViR1BQaUFoOWdMYWlZQjJkMGd4c1BRNEtCaGVF?oc=5" target="_blank"&gt;이엔셀, 인게니움과 'NK세포藥' 위탁생산 계약…미국 임상약물 추가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스맥&lt;/font&gt;</description><source url="http://www.newsmac.co.kr">뉴스맥</source></item><item><title>한국비엔씨-프로앱텍, 알부바디 기반 ADC 항암제 공동개발 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1uUW1GblE5bU5iOWZ4Zm1Ob0Nydi04OVFpMDRFX0pTcTNBaXRuZkQ5dnNxN3FaU2lZVVUzV3NXYUtyUk0wQUtJemtITEpRU3lLZVhhbnphODd0dWlUc0JlVVdWQTBMUFYwUkJj?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1uUW1GblE5bU5iOWZ4Zm1Ob0Nydi04OVFpMDRFX0pTcTNBaXRuZkQ5dnNxN3FaU2lZVVUzV3NXYUtyUk0wQUtJemtITEpRU3lLZVhhbnphODd0dWlUc0JlVVdWQTBMUFYwUkJj</guid><pubDate>Fri, 05 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1uUW1GblE5bU5iOWZ4Zm1Ob0Nydi04OVFpMDRFX0pTcTNBaXRuZkQ5dnNxN3FaU2lZVVUzV3NXYUtyUk0wQUtJemtITEpRU3lLZVhhbnphODd0dWlUc0JlVVdWQTBMUFYwUkJj?oc=5" target="_blank"&gt;한국비엔씨-프로앱텍, 알부바디 기반 ADC 항암제 공동개발 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>신라젠-신신제약, 전문의약품 수액제 공동판매 계약 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiS0FVX3lxTE5fNDVWdnl2TmQ2dVpmanlQdVVTTUFfWVE1UVF5Mm9hc2dPNWh4Z3hKMWRPTUxjNTAyVUxKWVVwcmlMZUdUYVk3X09Ubw?oc=5</link><guid isPermaLink="false">CBMiS0FVX3lxTE5fNDVWdnl2TmQ2dVpmanlQdVVTTUFfWVE1UVF5Mm9hc2dPNWh4Z3hKMWRPTUxjNTAyVUxKWVVwcmlMZUdUYVk3X09Ubw</guid><pubDate>Tue, 09 Jun 2026 00:45:21 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiS0FVX3lxTE5fNDVWdnl2TmQ2dVpmanlQdVVTTUFfWVE1UVF5Mm9hc2dPNWh4Z3hKMWRPTUxjNTAyVUxKWVVwcmlMZUdUYVk3X09Ubw?oc=5" target="_blank"&gt;신라젠-신신제약, 전문의약품 수액제 공동판매 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>온힐, CMG제약과 ‘72시간 통증 완화’ PF72 판매 계약 - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTFBvTjNySU1iMEpvOTVPSmREY0FLLVl2ZU5WNnAwNDQ3S0R2eWtDdlh3amp3blZENHhaSTctYXNFNWtOelBxQVcxeTVFVEcteFJfa2fSAVNBVV95cUxOQngtcXVnVkhlQ05nZ05mZnIwZVR0dWh2T3NWTkRpM0N1dExybVhwbnZGQ1NLWmtGM2ZqdW1BdUNyUThyVDU4dTBSbUQ1M29Tck5tNA?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTFBvTjNySU1iMEpvOTVPSmREY0FLLVl2ZU5WNnAwNDQ3S0R2eWtDdlh3amp3blZENHhaSTctYXNFNWtOelBxQVcxeTVFVEcteFJfa2fSAVNBVV95cUxOQngtcXVnVkhlQ05nZ05mZnIwZVR0dWh2T3NWTkRpM0N1dExybVhwbnZGQ1NLWmtGM2ZqdW1BdUNyUThyVDU4dTBSbUQ1M29Tck5tNA</guid><pubDate>Thu, 16 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBvTjNySU1iMEpvOTVPSmREY0FLLVl2ZU5WNnAwNDQ3S0R2eWtDdlh3amp3blZENHhaSTctYXNFNWtOelBxQVcxeTVFVEcteFJfa2fSAVNBVV95cUxOQngtcXVnVkhlQ05nZ05mZnIwZVR0dWh2T3NWTkRpM0N1dExybVhwbnZGQ1NLWmtGM2ZqdW1BdUNyUThyVDU4dTBSbUQ1M29Tck5tNA?oc=5" target="_blank"&gt;온힐, CMG제약과 ‘72시간 통증 완화’ PF72 판매 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>지투지바이오, 삼바에피스에 약물전달 기술이전..200억원 투자도 받기로 - 스마트투데이</title><link>https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Pa0NXOTdxSHBsUnRJeU1icWdtX1JTMTBKWFduSC12YmUzVW9Eb1pEZkNWaUNzU2pDenFTNlNwSEd3MzZJdG11OXpuSkxjUC1McllRY0hmTEVHcEQtWFYw?oc=5</link><guid isPermaLink="false">CBMiX0FVX3lxTE9Pa0NXOTdxSHBsUnRJeU1icWdtX1JTMTBKWFduSC12YmUzVW9Eb1pEZkNWaUNzU2pDenFTNlNwSEd3MzZJdG11OXpuSkxjUC1McllRY0hmTEVHcEQtWFYw</guid><pubDate>Mon, 16 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Pa0NXOTdxSHBsUnRJeU1icWdtX1JTMTBKWFduSC12YmUzVW9Eb1pEZkNWaUNzU2pDenFTNlNwSEd3MzZJdG11OXpuSkxjUC1McllRY0hmTEVHcEQtWFYw?oc=5" target="_blank"&gt;지투지바이오, 삼바에피스에 약물전달 기술이전..200억원 투자도 받기로&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;스마트투데이&lt;/font&gt;</description><source url="https://www.smarttoday.co.kr">스마트투데이</source></item><item><title>신테카바이오, 성균관대와 '약물 최적화' 용역 계약 체결 - 딜사이트</title><link>https://news.google.com/rss/articles/CBMiWEFVX3lxTFBNTVExYlJDTHBvZXducVhNT1JTeHJfdEp5anduLU51T3RMdzQ0c0hxZUdOLXk4WDB0VHBVM3E5eERxSi1BNVNfb21fY3NyS203VG9KY19vMnA?oc=5</link><guid isPermaLink="false">CBMiWEFVX3lxTFBNTVExYlJDTHBvZXducVhNT1JTeHJfdEp5anduLU51T3RMdzQ0c0hxZUdOLXk4WDB0VHBVM3E5eERxSi1BNVNfb21fY3NyS203VG9KY19vMnA</guid><pubDate>Thu, 25 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBNTVExYlJDTHBvZXducVhNT1JTeHJfdEp5anduLU51T3RMdzQ0c0hxZUdOLXk4WDB0VHBVM3E5eERxSi1BNVNfb21fY3NyS203VG9KY19vMnA?oc=5" target="_blank"&gt;신테카바이오, 성균관대와 '약물 최적화' 용역 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;딜사이트&lt;/font&gt;</description><source url="https://dealsite.co.kr">딜사이트</source></item><item><title>신테카바이오 ‘딥매처’로 AI 신약개발 성과 본격화 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE51S0hYNElORS1DWGdKanY0YWVZV2N4a1puUmZSZVBobENZR05XUDhfTWxvOVJfMUh0b3g1UGF6eFVHMTN4TGNlRDBOQmpZZmdRbzVZSzQ2Q2xTUE1PNkZnWHZPRWhLRHNyOWxHbVNB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE51S0hYNElORS1DWGdKanY0YWVZV2N4a1puUmZSZVBobENZR05XUDhfTWxvOVJfMUh0b3g1UGF6eFVHMTN4TGNlRDBOQmpZZmdRbzVZSzQ2Q2xTUE1PNkZnWHZPRWhLRHNyOWxHbVNB</guid><pubDate>Fri, 26 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE51S0hYNElORS1DWGdKanY0YWVZV2N4a1puUmZSZVBobENZR05XUDhfTWxvOVJfMUh0b3g1UGF6eFVHMTN4TGNlRDBOQmpZZmdRbzVZSzQ2Q2xTUE1PNkZnWHZPRWhLRHNyOWxHbVNB?oc=5" target="_blank"&gt;신테카바이오 ‘딥매처’로 AI 신약개발 성과 본격화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>온힐, CMG제약과 차세대 약물전달 의료기기 'PF72' 판매 계약 체결 - 데일리한국</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE92dVNqNlIxUklzRjhlZUFYYWkxc05SZko5UE9zdV8zWGJpVW90UjZJQ2RZbUVFWWpIb1RZVXFzWlVKTXVIYks5TDFKSXdxQktTSkRielc0bi1vWjRRZWVteUJ4UnVEODZtcU9zN19QZ9IBc0FVX3lxTFB3ZWdqNE5zeHRNLUJPbkJ0NEd4YU9heTZVdkVFZmtBRG9zWUpwUUVUQ05wcUR0Q1dfa3ZjVXYzV3ZjWTJvMVA3MjNaOTgxVUNvWldFSjFEV25ycDU3cG5WWGozTFFCSmlqTjRzREZFa0N6REE?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE92dVNqNlIxUklzRjhlZUFYYWkxc05SZko5UE9zdV8zWGJpVW90UjZJQ2RZbUVFWWpIb1RZVXFzWlVKTXVIYks5TDFKSXdxQktTSkRielc0bi1vWjRRZWVteUJ4UnVEODZtcU9zN19QZ9IBc0FVX3lxTFB3ZWdqNE5zeHRNLUJPbkJ0NEd4YU9heTZVdkVFZmtBRG9zWUpwUUVUQ05wcUR0Q1dfa3ZjVXYzV3ZjWTJvMVA3MjNaOTgxVUNvWldFSjFEV25ycDU3cG5WWGozTFFCSmlqTjRzREZFa0N6REE</guid><pubDate>Thu, 16 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE92dVNqNlIxUklzRjhlZUFYYWkxc05SZko5UE9zdV8zWGJpVW90UjZJQ2RZbUVFWWpIb1RZVXFzWlVKTXVIYks5TDFKSXdxQktTSkRielc0bi1vWjRRZWVteUJ4UnVEODZtcU9zN19QZ9IBc0FVX3lxTFB3ZWdqNE5zeHRNLUJPbkJ0NEd4YU9heTZVdkVFZmtBRG9zWUpwUUVUQ05wcUR0Q1dfa3ZjVXYzV3ZjWTJvMVA3MjNaOTgxVUNvWldFSjFEV25ycDU3cG5WWGozTFFCSmlqTjRzREZFa0N6REE?oc=5" target="_blank"&gt;온힐, CMG제약과 차세대 약물전달 의료기기 'PF72' 판매 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리한국&lt;/font&gt;</description><source url="https://daily.hankooki.com">데일리한국</source></item><item><title>삼천당제약, 경구 ‘리벨서스·위고비’ 제네릭 유럽 11개국 독점 라이선스 계약 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5iSWhKamZHb3Uxcmhmc2FKVkt0bDdmQ2xYUVJTWkZKRC1YX19GbDZ4RGh6TzB2Z3phcFlFTlFudVdTWHVKc0pYbmJSazVEMnVmUlZLMnM2c1NqNWRxWWNFaVowUGZKZnlBenFlStIBcEFVX3lxTFBtZXRWakpsWXEzbjh4SWdrSktxSVlZOTdGaGhJSzlLQWdtajBoZEhTNy1Rbzd2U05PdVd2X3dDNzdmc1NDYTVaeVNQT3FUR2RzZjczTkViOVNXRmd1Y29CMjVRb1R1UVJQRTYyWU9CbFQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5iSWhKamZHb3Uxcmhmc2FKVkt0bDdmQ2xYUVJTWkZKRC1YX19GbDZ4RGh6TzB2Z3phcFlFTlFudVdTWHVKc0pYbmJSazVEMnVmUlZLMnM2c1NqNWRxWWNFaVowUGZKZnlBenFlStIBcEFVX3lxTFBtZXRWakpsWXEzbjh4SWdrSktxSVlZOTdGaGhJSzlLQWdtajBoZEhTNy1Rbzd2U05PdVd2X3dDNzdmc1NDYTVaeVNQT3FUR2RzZjczTkViOVNXRmd1Y29CMjVRb1R1UVJQRTYyWU9CbFQ</guid><pubDate>Thu, 26 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5iSWhKamZHb3Uxcmhmc2FKVkt0bDdmQ2xYUVJTWkZKRC1YX19GbDZ4RGh6TzB2Z3phcFlFTlFudVdTWHVKc0pYbmJSazVEMnVmUlZLMnM2c1NqNWRxWWNFaVowUGZKZnlBenFlStIBcEFVX3lxTFBtZXRWakpsWXEzbjh4SWdrSktxSVlZOTdGaGhJSzlLQWdtajBoZEhTNy1Rbzd2U05PdVd2X3dDNzdmc1NDYTVaeVNQT3FUR2RzZjczTkViOVNXRmd1Y29CMjVRb1R1UVJQRTYyWU9CbFQ?oc=5" target="_blank"&gt;삼천당제약, 경구 ‘리벨서스·위고비’ 제네릭 유럽 11개국 독점 라이선스 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>지아이이노, 전립선암서 J&amp;J TCE 약물 병용요법 임상공급 계약 체결 - 파이낸스스코프</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFB2Tl9rRTBVTk5OSEhFVUpGZHFJUnRjZkdwUXhEOEM0YkE2Yko5bF9DcHBwYnBHQzRNOVpLSVVzbC1mSTl2Qm53dFNFRTAtZ2pRTjFJNkgyNHI1Y3h2N2ltQlpNMU5PZGQyZkE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFB2Tl9rRTBVTk5OSEhFVUpGZHFJUnRjZkdwUXhEOEM0YkE2Yko5bF9DcHBwYnBHQzRNOVpLSVVzbC1mSTl2Qm53dFNFRTAtZ2pRTjFJNkgyNHI1Y3h2N2ltQlpNMU5PZGQyZkE</guid><pubDate>Fri, 20 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFB2Tl9rRTBVTk5OSEhFVUpGZHFJUnRjZkdwUXhEOEM0YkE2Yko5bF9DcHBwYnBHQzRNOVpLSVVzbC1mSTl2Qm53dFNFRTAtZ2pRTjFJNkgyNHI1Y3h2N2ltQlpNMU5PZGQyZkE?oc=5" target="_blank"&gt;지아이이노, 전립선암서 J&amp;J TCE 약물 병용요법 임상공급 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸스스코프&lt;/font&gt;</description><source url="https://www.finance-scope.com">파이낸스스코프</source></item><item><title>美 할로자임, 버텍스와 ‘하이퍼콘’ 글로벌 라이선스 계약…220억원 규모·최대 3개 표적 적용 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1HT2NGbV9SNC1ORmhYWlpuak9GdEU4WTdHSjMyR1BlRmh2ZHV0VWU4VDBwTVJtcDk5RlJZN2kxeXBnenl0QUhvNXdUQi1TUkFEUmRFT29Za2ljU1FIMzdYWmU2VHBZT0dVcEhTUtIBcEFVX3lxTE1yYko4a1BwQXc5ZkRaWW9HSUwwTGRVODRoUllmWXBzVjJUR0IwdlUzSlgzaXVVY1Z2XzlOanRsYUZnZFBqYWFFUlcxQm53VUV1aTlPMFVCVEZ6eGxVVVVBM09zNk56eFdQdFo3QUpLcV8?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1HT2NGbV9SNC1ORmhYWlpuak9GdEU4WTdHSjMyR1BlRmh2ZHV0VWU4VDBwTVJtcDk5RlJZN2kxeXBnenl0QUhvNXdUQi1TUkFEUmRFT29Za2ljU1FIMzdYWmU2VHBZT0dVcEhTUtIBcEFVX3lxTE1yYko4a1BwQXc5ZkRaWW9HSUwwTGRVODRoUllmWXBzVjJUR0IwdlUzSlgzaXVVY1Z2XzlOanRsYUZnZFBqYWFFUlcxQm53VUV1aTlPMFVCVEZ6eGxVVVVBM09zNk56eFdQdFo3QUpLcV8</guid><pubDate>Wed, 08 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1HT2NGbV9SNC1ORmhYWlpuak9GdEU4WTdHSjMyR1BlRmh2ZHV0VWU4VDBwTVJtcDk5RlJZN2kxeXBnenl0QUhvNXdUQi1TUkFEUmRFT29Za2ljU1FIMzdYWmU2VHBZT0dVcEhTUtIBcEFVX3lxTE1yYko4a1BwQXc5ZkRaWW9HSUwwTGRVODRoUllmWXBzVjJUR0IwdlUzSlgzaXVVY1Z2XzlOanRsYUZnZFBqYWFFUlcxQm53VUV1aTlPMFVCVEZ6eGxVVVVBM09zNk56eFdQdFo3QUpLcV8?oc=5" target="_blank"&gt;美 할로자임, 버텍스와 ‘하이퍼콘’ 글로벌 라이선스 계약…220억원 규모·최대 3개 표적 적용&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>블랙컴뱃, 노블레스 주장에 정면 반박…"타 단체와 접촉·약물 복용 등 계약 위반 수두룩" - 랭크파이브</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE1CM1lCUE1zOGpVRENNUE5DLVVucEFDSFhlLTVKYVBRa3J6RmM4LWt0RTZoajdGTkRWOXBZYy1WQVZyYWNYNnUtU0ozb2cwUnNoOFRkcGlrVWR5T084M0FhMF9SUjg?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE1CM1lCUE1zOGpVRENNUE5DLVVucEFDSFhlLTVKYVBRa3J6RmM4LWt0RTZoajdGTkRWOXBZYy1WQVZyYWNYNnUtU0ozb2cwUnNoOFRkcGlrVWR5T084M0FhMF9SUjg</guid><pubDate>Mon, 29 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1CM1lCUE1zOGpVRENNUE5DLVVucEFDSFhlLTVKYVBRa3J6RmM4LWt0RTZoajdGTkRWOXBZYy1WQVZyYWNYNnUtU0ozb2cwUnNoOFRkcGlrVWR5T084M0FhMF9SUjg?oc=5" target="_blank"&gt;블랙컴뱃, 노블레스 주장에 정면 반박…"타 단체와 접촉·약물 복용 등 계약 위반 수두룩"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;랭크파이브&lt;/font&gt;</description><source url="https://www.rank5.kr">랭크파이브</source></item><item><title>리가켐바이오, 노바락에 'ADC용' 항체 1건 "계약 해지" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBnbjA5aFNiN1FMNkpTckd4YXFid2VtRDRJN2xKQWVSRnNESzZYS0Iwa1h1RVp1NzYxR3NuNUQ0VTZNTWJHSFlrbll0S2FmcFo3enpwN0IyNA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBnbjA5aFNiN1FMNkpTckd4YXFid2VtRDRJN2xKQWVSRnNESzZYS0Iwa1h1RVp1NzYxR3NuNUQ0VTZNTWJHSFlrbll0S2FmcFo3enpwN0IyNA</guid><pubDate>Thu, 02 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBnbjA5aFNiN1FMNkpTckd4YXFid2VtRDRJN2xKQWVSRnNESzZYS0Iwa1h1RVp1NzYxR3NuNUQ0VTZNTWJHSFlrbll0S2FmcFo3enpwN0IyNA?oc=5" target="_blank"&gt;리가켐바이오, 노바락에 'ADC용' 항체 1건 "계약 해지"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>㈜한국비엔씨, 미국 Leios Therapeutics사와 10XB-101 지방분해주사 후보약물의 9개국 독점제조 및 판권 라이센싱 계약체결 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5yX3AweEp1aFBJUEFOcjR1bW1fSktiUE5lc1M0cnJNX0h5RjhyX3J1c3NqR3dUd1U1Z3BsNmdVUlhEeU45WWZmTnQ3aTNWZjhGdjNmQklacUlEUdIBVEFVX3lxTE1mTmw2LWdQLUd3aUp4OGxxRFBYWHhkYXdmeDgyMW1rWTBhRzd0RXRCcnBJZDVJM196c3U5S2dDblBSZTVONldpQmVSYWxSelh6NHRrUw?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5yX3AweEp1aFBJUEFOcjR1bW1fSktiUE5lc1M0cnJNX0h5RjhyX3J1c3NqR3dUd1U1Z3BsNmdVUlhEeU45WWZmTnQ3aTNWZjhGdjNmQklacUlEUdIBVEFVX3lxTE1mTmw2LWdQLUd3aUp4OGxxRFBYWHhkYXdmeDgyMW1rWTBhRzd0RXRCcnBJZDVJM196c3U5S2dDblBSZTVONldpQmVSYWxSelh6NHRrUw</guid><pubDate>Mon, 26 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5yX3AweEp1aFBJUEFOcjR1bW1fSktiUE5lc1M0cnJNX0h5RjhyX3J1c3NqR3dUd1U1Z3BsNmdVUlhEeU45WWZmTnQ3aTNWZjhGdjNmQklacUlEUdIBVEFVX3lxTE1mTmw2LWdQLUd3aUp4OGxxRFBYWHhkYXdmeDgyMW1rWTBhRzd0RXRCcnBJZDVJM196c3U5S2dDblBSZTVONldpQmVSYWxSelh6NHRrUw?oc=5" target="_blank"&gt;㈜한국비엔씨, 미국 Leios Therapeutics사와 10XB-101 지방분해주사 후보약물의 9개국 독점제조 및 판권 라이센싱 계약체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>알테오젠, 美 바이오젠과 SC제형 개발 계약 - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxPUkdrUnhKamhSeXBjQ3czSHR0MnBoTHpRdzBwOVpDSjByZXQ1eWFhUTJUcDA0R0szTE9ZckFPbGM2LVR2T2RlejJQLXVZa1dFVkVQelozNUdtNTFOdE4zQTQ5akZPYjc2YngxUG1WMnpnTHpHWHhPdDRvYnFOVU1UUUkyTHhibTjSAZsBQVVfeXFMTnlqdDZBLXBKVEphUGliTHBQbGZIZGJyblY3LVhwQzY2S2pra1lQWTFwQkw3MTdZV0VFSmhmQXpIN3NUU3ZKaGxoS0JDcUpXWnNLd2ZibllDSXdJcGNVcENyVHJ6RnRQYlBETWc1NEo0T1d4UlJVLVg1QlZ4eU94RTIyLXJvNi1NSjF3Z1JwVmVJTVZERWZBUmZ2Ync?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxPUkdrUnhKamhSeXBjQ3czSHR0MnBoTHpRdzBwOVpDSjByZXQ1eWFhUTJUcDA0R0szTE9ZckFPbGM2LVR2T2RlejJQLXVZa1dFVkVQelozNUdtNTFOdE4zQTQ5akZPYjc2YngxUG1WMnpnTHpHWHhPdDRvYnFOVU1UUUkyTHhibTjSAZsBQVVfeXFMTnlqdDZBLXBKVEphUGliTHBQbGZIZGJyblY3LVhwQzY2S2pra1lQWTFwQkw3MTdZV0VFSmhmQXpIN3NUU3ZKaGxoS0JDcUpXWnNLd2ZibllDSXdJcGNVcENyVHJ6RnRQYlBETWc1NEo0T1d4UlJVLVg1QlZ4eU94RTIyLXJvNi1NSjF3Z1JwVmVJTVZERWZBUmZ2Ync</guid><pubDate>Wed, 25 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPUkdrUnhKamhSeXBjQ3czSHR0MnBoTHpRdzBwOVpDSjByZXQ1eWFhUTJUcDA0R0szTE9ZckFPbGM2LVR2T2RlejJQLXVZa1dFVkVQelozNUdtNTFOdE4zQTQ5akZPYjc2YngxUG1WMnpnTHpHWHhPdDRvYnFOVU1UUUkyTHhibTjSAZsBQVVfeXFMTnlqdDZBLXBKVEphUGliTHBQbGZIZGJyblY3LVhwQzY2S2pra1lQWTFwQkw3MTdZV0VFSmhmQXpIN3NUU3ZKaGxoS0JDcUpXWnNLd2ZibllDSXdJcGNVcENyVHJ6RnRQYlBETWc1NEo0T1d4UlJVLVg1QlZ4eU94RTIyLXJvNi1NSjF3Z1JwVmVJTVZERWZBUmZ2Ync?oc=5" target="_blank"&gt;알테오젠, 美 바이오젠과 SC제형 개발 계약 - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>올릭스, 스웨덴 키투브레인으로부터 약물전달기술 도입…CNS 질환 치료제 개발 본격화 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTFB3ejR3UFZLZnVGSFc1djJLQ1Y3SklCSEszWXdUMVF4VTdueTRoMGJXT29JT3RRcmxONkgtbTROMG4xZ0JQZk8xZnBrcGpXYzk5WTFuZ2p6c0dsd9IBVEFVX3lxTE1pbEFZb0h6STlDV3hvaDdOclZWTkRmbTAzSW5lWDBXY09waElBRkF4OE5XeFZyNTJ3N0JOT1RqdWV4UTIwZDRTWXdSTHM4Q3V3aS1odA?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTFB3ejR3UFZLZnVGSFc1djJLQ1Y3SklCSEszWXdUMVF4VTdueTRoMGJXT29JT3RRcmxONkgtbTROMG4xZ0JQZk8xZnBrcGpXYzk5WTFuZ2p6c0dsd9IBVEFVX3lxTE1pbEFZb0h6STlDV3hvaDdOclZWTkRmbTAzSW5lWDBXY09waElBRkF4OE5XeFZyNTJ3N0JOT1RqdWV4UTIwZDRTWXdSTHM4Q3V3aS1odA</guid><pubDate>Tue, 10 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFB3ejR3UFZLZnVGSFc1djJLQ1Y3SklCSEszWXdUMVF4VTdueTRoMGJXT29JT3RRcmxONkgtbTROMG4xZ0JQZk8xZnBrcGpXYzk5WTFuZ2p6c0dsd9IBVEFVX3lxTE1pbEFZb0h6STlDV3hvaDdOclZWTkRmbTAzSW5lWDBXY09waElBRkF4OE5XeFZyNTJ3N0JOT1RqdWV4UTIwZDRTWXdSTHM4Q3V3aS1odA?oc=5" target="_blank"&gt;올릭스, 스웨덴 키투브레인으로부터 약물전달기술 도입…CNS 질환 치료제 개발 본격화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>"하루도 편히 잠들지 못했다"…'금지 약물 복용+셀프 방출' 김재환, 논란 속 SSG 합류 - 네이트</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE1oV3owVGgxenJGcjkxQVhhd1VrdXFsWlhtREx0dHh1aURyWGhSRHpJU1p4MjFQeUVjOUF3SVNNcE11VG9yTFU3WGhFS0NxNXltTnhtc0d2RjctR2xV?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE1oV3owVGgxenJGcjkxQVhhd1VrdXFsWlhtREx0dHh1aURyWGhSRHpJU1p4MjFQeUVjOUF3SVNNcE11VG9yTFU3WGhFS0NxNXltTnhtc0d2RjctR2xV</guid><pubDate>Fri, 05 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1oV3owVGgxenJGcjkxQVhhd1VrdXFsWlhtREx0dHh1aURyWGhSRHpJU1p4MjFQeUVjOUF3SVNNcE11VG9yTFU3WGhFS0NxNXltTnhtc0d2RjctR2xV?oc=5" target="_blank"&gt;"하루도 편히 잠들지 못했다"…'금지 약물 복용+셀프 방출' 김재환, 논란 속 SSG 합류&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://sports.news.nate.com">네이트</source></item><item><title>릴리, 경구 비만약에 올인…펩트론 ‘스마트데포’ 본계약 안갯속 - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxNb0Y3dE9Na04zOHpXNks1ZWx0VzZkNklkT0k1YkpDRnh0dldUY0xZdTRPUDdrSHdOUDVRSm9CNW9LUG1mNXdaUDEwbzRXTGo3TE5UNncyQ3drVVQ3N1ZQbWpRSnhkNmJrR2szNzVGNXRkdzBMX2wwUjFvT3Y0NEw3NmtLcTJKTVHSAZsBQVVfeXFMUDNYa2RCaHBLS1o3aXJpaWFROW5PR3RmZ0FRN0ZEbVFuTTQxNFVPekxPeXg5eWdjX0dfeDN6SF9XNnZjdWlmMUhWS1VQTUEzS3ZqSjR3NktkZlVJZ19ObEZuYVZkWXZfQjc5MUtteVhBSnczMFRQeFBhLXZHRE43a0ZmQktaUGtOMjAwTG5wTXgydFVleGhESGFsS3c?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxNb0Y3dE9Na04zOHpXNks1ZWx0VzZkNklkT0k1YkpDRnh0dldUY0xZdTRPUDdrSHdOUDVRSm9CNW9LUG1mNXdaUDEwbzRXTGo3TE5UNncyQ3drVVQ3N1ZQbWpRSnhkNmJrR2szNzVGNXRkdzBMX2wwUjFvT3Y0NEw3NmtLcTJKTVHSAZsBQVVfeXFMUDNYa2RCaHBLS1o3aXJpaWFROW5PR3RmZ0FRN0ZEbVFuTTQxNFVPekxPeXg5eWdjX0dfeDN6SF9XNnZjdWlmMUhWS1VQTUEzS3ZqSjR3NktkZlVJZ19ObEZuYVZkWXZfQjc5MUtteVhBSnczMFRQeFBhLXZHRE43a0ZmQktaUGtOMjAwTG5wTXgydFVleGhESGFsS3c</guid><pubDate>Sun, 22 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNb0Y3dE9Na04zOHpXNks1ZWx0VzZkNklkT0k1YkpDRnh0dldUY0xZdTRPUDdrSHdOUDVRSm9CNW9LUG1mNXdaUDEwbzRXTGo3TE5UNncyQ3drVVQ3N1ZQbWpRSnhkNmJrR2szNzVGNXRkdzBMX2wwUjFvT3Y0NEw3NmtLcTJKTVHSAZsBQVVfeXFMUDNYa2RCaHBLS1o3aXJpaWFROW5PR3RmZ0FRN0ZEbVFuTTQxNFVPekxPeXg5eWdjX0dfeDN6SF9XNnZjdWlmMUhWS1VQTUEzS3ZqSjR3NktkZlVJZ19ObEZuYVZkWXZfQjc5MUtteVhBSnczMFRQeFBhLXZHRE43a0ZmQktaUGtOMjAwTG5wTXgydFVleGhESGFsS3c?oc=5" target="_blank"&gt;릴리, 경구 비만약에 올인…펩트론 ‘스마트데포’ 본계약 안갯속 - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>지투지, 유럽소재 빅파마와 '약효지속 플랫폼' 연구협력 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFA0dUJBMjBXcXJYWFFRdExjemRJV0Q3b1owR25sZk1BWTZiT2hRblExbllBZW5pTURRNVd0ZWg3X0p0bTFTUVhLaHhpdTc5VDFBTEsxYkZCaw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFA0dUJBMjBXcXJYWFFRdExjemRJV0Q3b1owR25sZk1BWTZiT2hRblExbllBZW5pTURRNVd0ZWg3X0p0bTFTUVhLaHhpdTc5VDFBTEsxYkZCaw</guid><pubDate>Mon, 29 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFA0dUJBMjBXcXJYWFFRdExjemRJV0Q3b1owR25sZk1BWTZiT2hRblExbllBZW5pTURRNVd0ZWg3X0p0bTFTUVhLaHhpdTc5VDFBTEsxYkZCaw?oc=5" target="_blank"&gt;지투지, 유럽소재 빅파마와 '약효지속 플랫폼' 연구협력&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>와이바이오, 우시바이오와 '삼중 면역항암' CDMO 계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE9RV2l4VGlpMTdwQXVXTkYycFphSklGWENfVmlRdjg2cVU5NWVfeWFsWVZXSUJMUk1iekU1Y2tkWWxiR09pWG5VTGJXbS1ESDBRLWxPNl9Paw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE9RV2l4VGlpMTdwQXVXTkYycFphSklGWENfVmlRdjg2cVU5NWVfeWFsWVZXSUJMUk1iekU1Y2tkWWxiR09pWG5VTGJXbS1ESDBRLWxPNl9Paw</guid><pubDate>Wed, 07 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9RV2l4VGlpMTdwQXVXTkYycFphSklGWENfVmlRdjg2cVU5NWVfeWFsWVZXSUJMUk1iekU1Y2tkWWxiR09pWG5VTGJXbS1ESDBRLWxPNl9Paw?oc=5" target="_blank"&gt;와이바이오, 우시바이오와 '삼중 면역항암' CDMO 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>트리오어, 셀트리온과 5220억 원 규모 플랫폼 기술이전·공동개발 계약 체결 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE5SZ0hValVGWE15Zk4xU0kwemRXeFFkRnp3eDBTN29YWk9wU3lEbFhfZVVnRWdWbEFfeHVRQTNiQU5Va1MzOHhnQ0V6Ykdpc1lycnVSY3ZGNA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE5SZ0hValVGWE15Zk4xU0kwemRXeFFkRnp3eDBTN29YWk9wU3lEbFhfZVVnRWdWbEFfeHVRQTNiQU5Va1MzOHhnQ0V6Ykdpc1lycnVSY3ZGNA</guid><pubDate>Wed, 19 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5SZ0hValVGWE15Zk4xU0kwemRXeFFkRnp3eDBTN29YWk9wU3lEbFhfZVVnRWdWbEFfeHVRQTNiQU5Va1MzOHhnQ0V6Ykdpc1lycnVSY3ZGNA?oc=5" target="_blank"&gt;트리오어, 셀트리온과 5220억 원 규모 플랫폼 기술이전·공동개발 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://www.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>신테카바이오, 메타비아와 AI 기반 약물 재창출 계약 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5JaDJPZGNDeUhzdkNPYVNOWkVRNEhUcEN0VnRRYlFDOWZnNFhrTjluVzhBQVQzcVl0TW5uX0w2OExpeG1WRm9HZnA4dUFsQU45WWRkXzNQUHRveDZoU081OXd0TFZMWjQ1UEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5JaDJPZGNDeUhzdkNPYVNOWkVRNEhUcEN0VnRRYlFDOWZnNFhrTjluVzhBQVQzcVl0TW5uX0w2OExpeG1WRm9HZnA4dUFsQU45WWRkXzNQUHRveDZoU081OXd0TFZMWjQ1UEE</guid><pubDate>Tue, 05 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5JaDJPZGNDeUhzdkNPYVNOWkVRNEhUcEN0VnRRYlFDOWZnNFhrTjluVzhBQVQzcVl0TW5uX0w2OExpeG1WRm9HZnA4dUFsQU45WWRkXzNQUHRveDZoU081OXd0TFZMWjQ1UEE?oc=5" target="_blank"&gt;신테카바이오, 메타비아와 AI 기반 약물 재창출 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>미국 이렇게 엉망이었나? '80G 약물 징계' 끝나지도 않았는데…케플러, 애리조나와 전격 계약→"PS 출전은 불가" - 엑스포츠뉴스</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE9kd3c4WTNxdkhOWVI1cEpzdmhoSTdaZmNidUJOeU9USXIwck5VczZrMFd0STh0WEVWV1lIMjJ4dmJPWlpwczhuWVRUbFhGUTlYSmw2Tw?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE9kd3c4WTNxdkhOWVI1cEpzdmhoSTdaZmNidUJOeU9USXIwck5VczZrMFd0STh0WEVWV1lIMjJ4dmJPWlpwczhuWVRUbFhGUTlYSmw2Tw</guid><pubDate>Mon, 08 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9kd3c4WTNxdkhOWVI1cEpzdmhoSTdaZmNidUJOeU9USXIwck5VczZrMFd0STh0WEVWV1lIMjJ4dmJPWlpwczhuWVRUbFhGUTlYSmw2Tw?oc=5" target="_blank"&gt;미국 이렇게 엉망이었나? '80G 약물 징계' 끝나지도 않았는데…케플러, 애리조나와 전격 계약→"PS 출전은 불가"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;엑스포츠뉴스&lt;/font&gt;</description><source url="https://www.xportsnews.com">엑스포츠뉴스</source></item><item><title>AI가 찾은 신약, 특허·수익은 누가?…"계약으로 풀어야 할 법적 공백 커" - 동아사이언스</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE51RDQwb1l1ZUViVUpveXZBQnh2VWtnLWJjNXVUazZqLW44S0xwd25NZHJMcENrbE5CTXY0eUlXU19ZaC1aSWlWNlA0bUlaSTYwUTFGYQ?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE51RDQwb1l1ZUViVUpveXZBQnh2VWtnLWJjNXVUazZqLW44S0xwd25NZHJMcENrbE5CTXY0eUlXU19ZaC1aSWlWNlA0bUlaSTYwUTFGYQ</guid><pubDate>Wed, 18 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE51RDQwb1l1ZUViVUpveXZBQnh2VWtnLWJjNXVUazZqLW44S0xwd25NZHJMcENrbE5CTXY0eUlXU19ZaC1aSWlWNlA0bUlaSTYwUTFGYQ?oc=5" target="_blank"&gt;AI가 찾은 신약, 특허·수익은 누가?…"계약으로 풀어야 할 법적 공백 커"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;동아사이언스&lt;/font&gt;</description><source url="https://www.dongascience.com">동아사이언스</source></item><item><title>체포 당일에도 사용…日 야구계 충격 빠뜨린 '좀비 담배' 파문, 결국 계약 해지 - 네이트</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTFB2RGFaMUVuelFJZm00ZWs2a0haeEFaRXdOd016eUhDcTd0WVFRclU1UWFZX2tKeEdyT2ptVWtlT1I1VDNnanhkcS1Gc2ZMc0Y0VDl3aF9sVlhiLTU4?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTFB2RGFaMUVuelFJZm00ZWs2a0haeEFaRXdOd016eUhDcTd0WVFRclU1UWFZX2tKeEdyT2ptVWtlT1I1VDNnanhkcS1Gc2ZMc0Y0VDl3aF9sVlhiLTU4</guid><pubDate>Wed, 25 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFB2RGFaMUVuelFJZm00ZWs2a0haeEFaRXdOd016eUhDcTd0WVFRclU1UWFZX2tKeEdyT2ptVWtlT1I1VDNnanhkcS1Gc2ZMc0Y0VDl3aF9sVlhiLTU4?oc=5" target="_blank"&gt;체포 당일에도 사용…日 야구계 충격 빠뜨린 '좀비 담배' 파문, 결국 계약 해지&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://sports.news.nate.com">네이트</source></item><item><title>지투지바이오, 베링거와 ‘장기지속 주사제’ 협력 "확대" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBIU2JJczBiMHBoTnhvdTByWW52akdiSUxnQm91bzl4ekhHekQzMC1ISjNPUXJCUE9sSTZFblN0bVpCTXVsbkhVU2d4QVJQLXp5bTdVNWhpYw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBIU2JJczBiMHBoTnhvdTByWW52akdiSUxnQm91bzl4ekhHekQzMC1ISjNPUXJCUE9sSTZFblN0bVpCTXVsbkhVU2d4QVJQLXp5bTdVNWhpYw</guid><pubDate>Mon, 14 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBIU2JJczBiMHBoTnhvdTByWW52akdiSUxnQm91bzl4ekhHekQzMC1ISjNPUXJCUE9sSTZFblN0bVpCTXVsbkhVU2d4QVJQLXp5bTdVNWhpYw?oc=5" target="_blank"&gt;지투지바이오, 베링거와 ‘장기지속 주사제’ 협력 "확대"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>신테카바이오-엔바이오스, 암질환 치료제 타깃 약물최적화 계약 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKSzZ4REVLc2xvSnZlTDBTb2JoemM0aUhMY01IYTQ3dDdtQTFBd0ZKYmdsOVVTOUtJLVJrZ29Kc2czQ3lPOGZMdUttVFl1RTVWSUhUdFpMMllqNUd1dVNOVnNxQmEwQQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFBKSzZ4REVLc2xvSnZlTDBTb2JoemM0aUhMY01IYTQ3dDdtQTFBd0ZKYmdsOVVTOUtJLVJrZ29Kc2czQ3lPOGZMdUttVFl1RTVWSUhUdFpMMllqNUd1dVNOVnNxQmEwQQ</guid><pubDate>Fri, 26 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKSzZ4REVLc2xvSnZlTDBTb2JoemM0aUhMY01IYTQ3dDdtQTFBd0ZKYmdsOVVTOUtJLVJrZ29Kc2czQ3lPOGZMdUttVFl1RTVWSUhUdFpMMllqNUd1dVNOVnNxQmEwQQ?oc=5" target="_blank"&gt;신테카바이오-엔바이오스, 암질환 치료제 타깃 약물최적화 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>'약물 전달 플랫폼' 지투지바이오, 유럽 제약사와 약효지속성 주사제 연구협력 계약 - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTE12eF9oUGx5TG1HeXdGR2J1LUNncTNic0YybXlXbHlnci1haUxVTXhBODBJQTBOYlo5Z29XajNfcDBwcGczdGw0MWNkLUdhd2E5dGfSAVNBVV95cUxQMXFFWDVsTjYtS0EyRlJ0dUN4R1ZrSDJvMmh1Ym1WclZzZmRMdEtMWmpQYWh3aE5LM0pvNk1jc1pZTlJJMXdzM2F4b1l1Q054bnRpNA?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTE12eF9oUGx5TG1HeXdGR2J1LUNncTNic0YybXlXbHlnci1haUxVTXhBODBJQTBOYlo5Z29XajNfcDBwcGczdGw0MWNkLUdhd2E5dGfSAVNBVV95cUxQMXFFWDVsTjYtS0EyRlJ0dUN4R1ZrSDJvMmh1Ym1WclZzZmRMdEtMWmpQYWh3aE5LM0pvNk1jc1pZTlJJMXdzM2F4b1l1Q054bnRpNA</guid><pubDate>Mon, 29 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE12eF9oUGx5TG1HeXdGR2J1LUNncTNic0YybXlXbHlnci1haUxVTXhBODBJQTBOYlo5Z29XajNfcDBwcGczdGw0MWNkLUdhd2E5dGfSAVNBVV95cUxQMXFFWDVsTjYtS0EyRlJ0dUN4R1ZrSDJvMmh1Ym1WclZzZmRMdEtMWmpQYWh3aE5LM0pvNk1jc1pZTlJJMXdzM2F4b1l1Q054bnRpNA?oc=5" target="_blank"&gt;'약물 전달 플랫폼' 지투지바이오, 유럽 제약사와 약효지속성 주사제 연구협력 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>입셀, 오노와 ‘iPSC 기반’ 효능평가 서비스 계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmOHFmN3BYYXlhY3FaLVpaSTZvR21kQUFxUFNaSExubVNQM2xhOWhVNjBzcnhPN3QwM0VCM3NXX195R3FobUYwMC1mNjMydFYtelQyQThJYw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBmOHFmN3BYYXlhY3FaLVpaSTZvR21kQUFxUFNaSExubVNQM2xhOWhVNjBzcnhPN3QwM0VCM3NXX195R3FobUYwMC1mNjMydFYtelQyQThJYw</guid><pubDate>Thu, 11 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBmOHFmN3BYYXlhY3FaLVpaSTZvR21kQUFxUFNaSExubVNQM2xhOWhVNjBzcnhPN3QwM0VCM3NXX195R3FobUYwMC1mNjMydFYtelQyQThJYw?oc=5" target="_blank"&gt;입셀, 오노와 ‘iPSC 기반’ 효능평가 서비스 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>DXVX 에빅스젠, 美바이오텍과 약물전달 플랫폼 기술이전 계약 - 중소기업신문</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9ZeS1CMHBMejlZN25zMS12OUhtbVZoQVJvNV9CdGhnN2I4dmlKcmZnQ1hjVG9pTXVBRmpuUUlidFBkb05hV0djNEVGTXYwR3hLYUh4allaYTJLTVQxTzJ6R0htOHJrRV9kLWdZeFJB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9ZeS1CMHBMejlZN25zMS12OUhtbVZoQVJvNV9CdGhnN2I4dmlKcmZnQ1hjVG9pTXVBRmpuUUlidFBkb05hV0djNEVGTXYwR3hLYUh4allaYTJLTVQxTzJ6R0htOHJrRV9kLWdZeFJB</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9ZeS1CMHBMejlZN25zMS12OUhtbVZoQVJvNV9CdGhnN2I4dmlKcmZnQ1hjVG9pTXVBRmpuUUlidFBkb05hV0djNEVGTXYwR3hLYUh4allaYTJLTVQxTzJ6R0htOHJrRV9kLWdZeFJB?oc=5" target="_blank"&gt;DXVX 에빅스젠, 美바이오텍과 약물전달 플랫폼 기술이전 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;중소기업신문&lt;/font&gt;</description><source url="https://www.smedaily.co.kr">중소기업신문</source></item><item><title>에빅스젠,미국 바이오기업과 5천억 규모 차세대 약물전달 플랫폼 라이선스 아웃 계약 - 약업신문</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE9WbkpsR3ExOXlxaHhqY21YODdxdlNwaDU3dE1FUzRpeDBnSFlib1p4V1BBc3M4WWp1TzBKclFFbkRsNTBmM3Nsa1BwWFctQlRZelBiVV9zU1g5Vk43ZE1DMjZNZXB3eFVPREJLVjF1MA?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE9WbkpsR3ExOXlxaHhqY21YODdxdlNwaDU3dE1FUzRpeDBnSFlib1p4V1BBc3M4WWp1TzBKclFFbkRsNTBmM3Nsa1BwWFctQlRZelBiVV9zU1g5Vk43ZE1DMjZNZXB3eFVPREJLVjF1MA</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9WbkpsR3ExOXlxaHhqY21YODdxdlNwaDU3dE1FUzRpeDBnSFlib1p4V1BBc3M4WWp1TzBKclFFbkRsNTBmM3Nsa1BwWFctQlRZelBiVV9zU1g5Vk43ZE1DMjZNZXB3eFVPREJLVjF1MA?oc=5" target="_blank"&gt;에빅스젠,미국 바이오기업과 5천억 규모 차세대 약물전달 플랫폼 라이선스 아웃 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>'12살에 금지약물 적발!'…필라델피아, 130만 달러 계약 전격 철회 ‘충격’ - 인터풋볼</title><link>https://news.google.com/rss/articles/CBMidEFVX3lxTFByUFJ4V1Y4b3BHdG81Z1RBUWJPT1YwY0JfUk9zNU1QZWVIUkNicEtEWS1vd2NwR1VMNlFEMktYX2FIMXlsaTJPQXEwMGR2dEZXME1PYzBXdjJaUGVmTmg4eDZFR1ZFdzdGYXVsSHAxVFE3QUxB?oc=5</link><guid isPermaLink="false">CBMidEFVX3lxTFByUFJ4V1Y4b3BHdG81Z1RBUWJPT1YwY0JfUk9zNU1QZWVIUkNicEtEWS1vd2NwR1VMNlFEMktYX2FIMXlsaTJPQXEwMGR2dEZXME1PYzBXdjJaUGVmTmg4eDZFR1ZFdzdGYXVsSHAxVFE3QUxB</guid><pubDate>Fri, 27 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidEFVX3lxTFByUFJ4V1Y4b3BHdG81Z1RBUWJPT1YwY0JfUk9zNU1QZWVIUkNicEtEWS1vd2NwR1VMNlFEMktYX2FIMXlsaTJPQXEwMGR2dEZXME1PYzBXdjJaUGVmTmg4eDZFR1ZFdzdGYXVsSHAxVFE3QUxB?oc=5" target="_blank"&gt;'12살에 금지약물 적발!'…필라델피아, 130만 달러 계약 전격 철회 ‘충격’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;인터풋볼&lt;/font&gt;</description><source url="https://www.interfootball.co.kr">인터풋볼</source></item><item><title>상장 두 달 만에 '날벼락'…인투셀, 기술이전 계약 해지에 급락 - 마켓인</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE5hWjZ6Wk1sRGRuV0Q5WG1SSTRzRXdQM0VfMnFoSEItRDM4TFZFSkZtZnBIRGJER0J5UzN3M2tVOGlNZEh2TmdKeVFwcnVGWEJBMVhXQ3lsOGhfVXJSZEtOMHlfMG9LbXZNaUF6cVA0Z1ZXQU0?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE5hWjZ6Wk1sRGRuV0Q5WG1SSTRzRXdQM0VfMnFoSEItRDM4TFZFSkZtZnBIRGJER0J5UzN3M2tVOGlNZEh2TmdKeVFwcnVGWEJBMVhXQ3lsOGhfVXJSZEtOMHlfMG9LbXZNaUF6cVA0Z1ZXQU0</guid><pubDate>Thu, 10 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE5hWjZ6Wk1sRGRuV0Q5WG1SSTRzRXdQM0VfMnFoSEItRDM4TFZFSkZtZnBIRGJER0J5UzN3M2tVOGlNZEh2TmdKeVFwcnVGWEJBMVhXQ3lsOGhfVXJSZEtOMHlfMG9LbXZNaUF6cVA0Z1ZXQU0?oc=5" target="_blank"&gt;상장 두 달 만에 '날벼락'…인투셀, 기술이전 계약 해지에 급락&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;마켓인&lt;/font&gt;</description><source url="https://marketin.edaily.co.kr">마켓인</source></item><item><title>디엑스앤브이엑스 자회사 에빅스젠, 美 바이오 기업과 5,000억 원 규모 라이선스 아웃 계약 체결 - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5hNGM0a1hSSUNtNGtrd0J1UzdkZGcxWWQ4VXBobEtfaC03RzBkVU5XbS1UY21iazRDVUdzMG9WWTJ2eWQ0bWVfQ1NLeXNKSzlfMjFST3Q0WUJoRW5wMjZiYVJCWDRYcmxpd2lybA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5hNGM0a1hSSUNtNGtrd0J1UzdkZGcxWWQ4VXBobEtfaC03RzBkVU5XbS1UY21iazRDVUdzMG9WWTJ2eWQ0bWVfQ1NLeXNKSzlfMjFST3Q0WUJoRW5wMjZiYVJCWDRYcmxpd2lybA</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5hNGM0a1hSSUNtNGtrd0J1UzdkZGcxWWQ4VXBobEtfaC03RzBkVU5XbS1UY21iazRDVUdzMG9WWTJ2eWQ0bWVfQ1NLeXNKSzlfMjFST3Q0WUJoRW5wMjZiYVJCWDRYcmxpd2lybA?oc=5" target="_blank"&gt;디엑스앤브이엑스 자회사 에빅스젠, 美 바이오 기업과 5,000억 원 규모 라이선스 아웃 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>셀트리온, 신약개발에 박차…美바이오텍과 항체 신약 2종 라이선스 인 계약 체결 - 한경매거진&amp;북</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBYcl93V2Izclh2QV9XVEhSQlFmc3JscVZLTnpuTEllQWFwX0ZFLWZHaUVCYmZ3RTNwcUNDeG9CTnVhRUozanNrb2FOaTFXVk1WZzAtdERWdEZQdzFrLWxtWnVBYzE3Wm9jMUVLSQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBYcl93V2Izclh2QV9XVEhSQlFmc3JscVZLTnpuTEllQWFwX0ZFLWZHaUVCYmZ3RTNwcUNDeG9CTnVhRUozanNrb2FOaTFXVk1WZzAtdERWdEZQdzFrLWxtWnVBYzE3Wm9jMUVLSQ</guid><pubDate>Tue, 04 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBYcl93V2Izclh2QV9XVEhSQlFmc3JscVZLTnpuTEllQWFwX0ZFLWZHaUVCYmZ3RTNwcUNDeG9CTnVhRUozanNrb2FOaTFXVk1WZzAtdERWdEZQdzFrLWxtWnVBYzE3Wm9jMUVLSQ?oc=5" target="_blank"&gt;셀트리온, 신약개발에 박차…美바이오텍과 항체 신약 2종 라이선스 인 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한경매거진&amp;북&lt;/font&gt;</description><source url="https://magazine.hankyung.com">한경매거진&amp;북</source></item><item><title>지투지바이오 "BI와 장기지속형 주사제 개발 추가 계약" - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1WWF80SDAxSy1lOWpUU1Zyc082b3BNMGVOcEN3VVBxNy1tSC1vVHN4LV9aaXc3MWxMV1NzTm5EbjRtSkplRUJ3ejFCcDV0Ynh3RnYtMXFabkhiYlhJd2dHUlRjZkhiZGlwRXlPMks1SdIBc0FVX3lxTE1oLThRSGJNMkJYd0JYX1lzdlp6TUl3R2VVM0tuaF9QSmdnQjVwTXNILWhVcDRGdzJUWnlyODJGQzhxbXZKUm1GbmZWeXBrSmpjd0J3UjlFOW05ZkFiTGRsTjJHVkhrVktab1c5RlgyZlN3YTA?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1WWF80SDAxSy1lOWpUU1Zyc082b3BNMGVOcEN3VVBxNy1tSC1vVHN4LV9aaXc3MWxMV1NzTm5EbjRtSkplRUJ3ejFCcDV0Ynh3RnYtMXFabkhiYlhJd2dHUlRjZkhiZGlwRXlPMks1SdIBc0FVX3lxTE1oLThRSGJNMkJYd0JYX1lzdlp6TUl3R2VVM0tuaF9QSmdnQjVwTXNILWhVcDRGdzJUWnlyODJGQzhxbXZKUm1GbmZWeXBrSmpjd0J3UjlFOW05ZkFiTGRsTjJHVkhrVktab1c5RlgyZlN3YTA</guid><pubDate>Mon, 14 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1WWF80SDAxSy1lOWpUU1Zyc082b3BNMGVOcEN3VVBxNy1tSC1vVHN4LV9aaXc3MWxMV1NzTm5EbjRtSkplRUJ3ejFCcDV0Ynh3RnYtMXFabkhiYlhJd2dHUlRjZkhiZGlwRXlPMks1SdIBc0FVX3lxTE1oLThRSGJNMkJYd0JYX1lzdlp6TUl3R2VVM0tuaF9QSmdnQjVwTXNILWhVcDRGdzJUWnlyODJGQzhxbXZKUm1GbmZWeXBrSmpjd0J3UjlFOW05ZkFiTGRsTjJHVkhrVktab1c5RlgyZlN3YTA?oc=5" target="_blank"&gt;지투지바이오 "BI와 장기지속형 주사제 개발 추가 계약"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>에빅스젠, 차세대 약물전달 플랫폼 5000억 규모 美 권리 이전 계약 - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5zbjVkWEtBSnRmQTRESEVOTmlDMk9nY3pUY3pXVVkwSkZ3dFRhS2QzcEgybC03Q25zOWZNZHFsYVVXbjdza2VpX3RPV292OFFQaHVGbnBycDZ6TTFDMzlaQy04MjVMNjF3YnfSAW9BVV95cUxPMTd0dDdBb1hwRTRLV0owdE1LSDNlMXVMbF85Z211ekRwTV9HVFNJT0hYZi1Mdm5ya2J2QVhzRXhxWTlMaFBOeHMxWldmNVVhQzgxa0lTc0VaelR3OUlTMHlCMHgtZ0YzeFZDOW9STzg?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5zbjVkWEtBSnRmQTRESEVOTmlDMk9nY3pUY3pXVVkwSkZ3dFRhS2QzcEgybC03Q25zOWZNZHFsYVVXbjdza2VpX3RPV292OFFQaHVGbnBycDZ6TTFDMzlaQy04MjVMNjF3YnfSAW9BVV95cUxPMTd0dDdBb1hwRTRLV0owdE1LSDNlMXVMbF85Z211ekRwTV9HVFNJT0hYZi1Mdm5ya2J2QVhzRXhxWTlMaFBOeHMxWldmNVVhQzgxa0lTc0VaelR3OUlTMHlCMHgtZ0YzeFZDOW9STzg</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5zbjVkWEtBSnRmQTRESEVOTmlDMk9nY3pUY3pXVVkwSkZ3dFRhS2QzcEgybC03Q25zOWZNZHFsYVVXbjdza2VpX3RPV292OFFQaHVGbnBycDZ6TTFDMzlaQy04MjVMNjF3YnfSAW9BVV95cUxPMTd0dDdBb1hwRTRLV0owdE1LSDNlMXVMbF85Z211ekRwTV9HVFNJT0hYZi1Mdm5ya2J2QVhzRXhxWTlMaFBOeHMxWldmNVVhQzgxa0lTc0VaelR3OUlTMHlCMHgtZ0YzeFZDOW9STzg?oc=5" target="_blank"&gt;에빅스젠, 차세대 약물전달 플랫폼 5000억 규모 美 권리 이전 계약 - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>대웅제약-대웅테라퓨틱스, '마이크로니들' 글로벌 전용실시권 계약 - 핀포인트뉴스</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE5RYkZjZnlBTEJGTjdYdzV6UEVIVXdvOFBEdVRUNHg4emhZbzBwX1VIY1phU0h6QlVTN3E4MTFabVhELWNEalY0Q0hQcHBRZ3VEb3lxb1h1YWNzNmxONlFrSEktOGVra0w4VDhEZ3NZUjJ5VnfSAXdBVV95cUxQbTZpT05tdFJTQ2ZOSE1QWGQ0cEFfSFpnVDAwOHQtbGtPOVo3bVBHOGEyWXlza05HVnJWaExKbjVYMzEwXzIyUUZic20zQ2dZZWN5d25sRFBmaW4tNGdYUVl4eVllNjljYUszMGFYaGRCN1QtVnpGSQ?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE5RYkZjZnlBTEJGTjdYdzV6UEVIVXdvOFBEdVRUNHg4emhZbzBwX1VIY1phU0h6QlVTN3E4MTFabVhELWNEalY0Q0hQcHBRZ3VEb3lxb1h1YWNzNmxONlFrSEktOGVra0w4VDhEZ3NZUjJ5VnfSAXdBVV95cUxQbTZpT05tdFJTQ2ZOSE1QWGQ0cEFfSFpnVDAwOHQtbGtPOVo3bVBHOGEyWXlza05HVnJWaExKbjVYMzEwXzIyUUZic20zQ2dZZWN5d25sRFBmaW4tNGdYUVl4eVllNjljYUszMGFYaGRCN1QtVnpGSQ</guid><pubDate>Wed, 25 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE5RYkZjZnlBTEJGTjdYdzV6UEVIVXdvOFBEdVRUNHg4emhZbzBwX1VIY1phU0h6QlVTN3E4MTFabVhELWNEalY0Q0hQcHBRZ3VEb3lxb1h1YWNzNmxONlFrSEktOGVra0w4VDhEZ3NZUjJ5VnfSAXdBVV95cUxQbTZpT05tdFJTQ2ZOSE1QWGQ0cEFfSFpnVDAwOHQtbGtPOVo3bVBHOGEyWXlza05HVnJWaExKbjVYMzEwXzIyUUZic20zQ2dZZWN5d25sRFBmaW4tNGdYUVl4eVllNjljYUszMGFYaGRCN1QtVnpGSQ?oc=5" target="_blank"&gt;대웅제약-대웅테라퓨틱스, '마이크로니들' 글로벌 전용실시권 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;핀포인트뉴스&lt;/font&gt;</description><source url="https://www.pinpointnews.co.kr">핀포인트뉴스</source></item><item><title>사이로나크스, 노바티스에 BBB 약물 전달 플랫폼 독점 인수 옵션 부여 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBQTVJlaEo2NGZaR0pMOFZKT1FQX2F3UHVmZjQ0UHZoWUNIWUh3eWVRd19mdWdOM0xjUjRoSHA2bXpwWmhPdWlMVmFmRTdURHdId05pZS1XRzhXalMzRUhqY3ZRRlFvOElJY2xz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBQTVJlaEo2NGZaR0pMOFZKT1FQX2F3UHVmZjQ0UHZoWUNIWUh3eWVRd19mdWdOM0xjUjRoSHA2bXpwWmhPdWlMVmFmRTdURHdId05pZS1XRzhXalMzRUhqY3ZRRlFvOElJY2xz</guid><pubDate>Thu, 10 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBQTVJlaEo2NGZaR0pMOFZKT1FQX2F3UHVmZjQ0UHZoWUNIWUh3eWVRd19mdWdOM0xjUjRoSHA2bXpwWmhPdWlMVmFmRTdURHdId05pZS1XRzhXalMzRUhqY3ZRRlFvOElJY2xz?oc=5" target="_blank"&gt;사이로나크스, 노바티스에 BBB 약물 전달 플랫폼 독점 인수 옵션 부여&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>"OHPAS·PMT 기술, 특허 이슈 없어" - 딜사이트</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1ySnVlNW9Sa0luTnU2SlRnelNSWE4yRUFlaW9mOTZfSGxLbnFxM21XV2hxbE53Uk5sV1FuVWFSd1NzRGhLU29rRzFYQTlIS0U?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1ySnVlNW9Sa0luTnU2SlRnelNSWE4yRUFlaW9mOTZfSGxLbnFxM21XV2hxbE53Uk5sV1FuVWFSd1NzRGhLU29rRzFYQTlIS0U</guid><pubDate>Fri, 11 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1ySnVlNW9Sa0luTnU2SlRnelNSWE4yRUFlaW9mOTZfSGxLbnFxM21XV2hxbE53Uk5sV1FuVWFSd1NzRGhLU29rRzFYQTlIS0U?oc=5" target="_blank"&gt;"OHPAS·PMT 기술, 특허 이슈 없어"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;딜사이트&lt;/font&gt;</description><source url="https://dealsite.co.kr">딜사이트</source></item><item><title>인투셀 주가 장중 25% 급락, 항체·약물 플랫폼 기술이전 계약 해지 소식 영향 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9JWVpqeDBOd0p1LUlBQXZIcDFHaERuZzc3amgySjMwMjNSbnhHVlUtWlptNkU5cFBEWDJBaVY1X05ib0ZlWGEtV0Z2em9ydDZUREVyWGhQZTBNY0Z2Uzc5Ul9TMmZHNGJaVi1pcjNMSkd4dXM?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9JWVpqeDBOd0p1LUlBQXZIcDFHaERuZzc3amgySjMwMjNSbnhHVlUtWlptNkU5cFBEWDJBaVY1X05ib0ZlWGEtV0Z2em9ydDZUREVyWGhQZTBNY0Z2Uzc5Ul9TMmZHNGJaVi1pcjNMSkd4dXM</guid><pubDate>Thu, 10 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9JWVpqeDBOd0p1LUlBQXZIcDFHaERuZzc3amgySjMwMjNSbnhHVlUtWlptNkU5cFBEWDJBaVY1X05ib0ZlWGEtV0Z2em9ydDZUREVyWGhQZTBNY0Z2Uzc5Ul9TMmZHNGJaVi1pcjNMSkd4dXM?oc=5" target="_blank"&gt;인투셀 주가 장중 25% 급락, 항체·약물 플랫폼 기술이전 계약 해지 소식 영향&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>"끝내 울었다"... '금지약물 복용 사태→18개월 자격 정지' 포그바, 전격 복귀! 모나코와 계약 후 눈물 펑펑 - 조선일보</title><link>https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZzNEUWh4Z1N0V3haZWp6QWgtSTRtbUxTSnFScnhlV2tyNGNFUW5fQVN3SXZ1U1BMT29KWkRCOVp0UVFsQ1lyS1JrbTZyQ3BDN3huNzZ2QnNVa2VRdkVwTWhYZ1lQdHpCZVUtN0ExVWhBaU5Ndy1QQlY1VnFBZWs3cFl2eDJZZmt5X01r?oc=5</link><guid isPermaLink="false">CBMiiwFBVV95cUxOZzNEUWh4Z1N0V3haZWp6QWgtSTRtbUxTSnFScnhlV2tyNGNFUW5fQVN3SXZ1U1BMT29KWkRCOVp0UVFsQ1lyS1JrbTZyQ3BDN3huNzZ2QnNVa2VRdkVwTWhYZ1lQdHpCZVUtN0ExVWhBaU5Ndy1QQlY1VnFBZWs3cFl2eDJZZmt5X01r</guid><pubDate>Sun, 29 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZzNEUWh4Z1N0V3haZWp6QWgtSTRtbUxTSnFScnhlV2tyNGNFUW5fQVN3SXZ1U1BMT29KWkRCOVp0UVFsQ1lyS1JrbTZyQ3BDN3huNzZ2QnNVa2VRdkVwTWhYZ1lQdHpCZVUtN0ExVWhBaU5Ndy1QQlY1VnFBZWs3cFl2eDJZZmt5X01r?oc=5" target="_blank"&gt;"끝내 울었다"... '금지약물 복용 사태→18개월 자격 정지' 포그바, 전격 복귀! 모나코와 계약 후 눈물 펑펑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;조선일보&lt;/font&gt;</description><source url="https://www.chosun.com">조선일보</source></item><item><title>바이오사이토젠, 혁신적인 약물 개발을 가속화하기 위해 비원 메디신스와 항체 라이선스 계약 체결 - 뉴스와이어</title><link>https://news.google.com/rss/articles/CBMiX0FVX3lxTE4yTXFqZEMxQ1JHb3poNndMT2gxQWtKbk51WTJhWXloVGRNUllfRXVuUXNTTW1yZGZlRzJCRUVOM2tuSUlsdllSWHk5eWx3TklWWldyN3NrTTc2d0ItdVY0?oc=5</link><guid isPermaLink="false">CBMiX0FVX3lxTE4yTXFqZEMxQ1JHb3poNndMT2gxQWtKbk51WTJhWXloVGRNUllfRXVuUXNTTW1yZGZlRzJCRUVOM2tuSUlsdllSWHk5eWx3TklWWldyN3NrTTc2d0ItdVY0</guid><pubDate>Fri, 11 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4yTXFqZEMxQ1JHb3poNndMT2gxQWtKbk51WTJhWXloVGRNUllfRXVuUXNTTW1yZGZlRzJCRUVOM2tuSUlsdllSWHk5eWx3TklWWldyN3NrTTc2d0ItdVY0?oc=5" target="_blank"&gt;바이오사이토젠, 혁신적인 약물 개발을 가속화하기 위해 비원 메디신스와 항체 라이선스 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스와이어&lt;/font&gt;</description><source url="https://www.newswire.co.kr">뉴스와이어</source></item><item><title>지투지바이오-베링거인겔하임, 장기지속형 주사제 개발 협력 확대…제형 개발 추가 계약 성사 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE94Q29ia2UwSHQyYlpsX0NqRTJRVFZvTjJjZ3lzb0pjUTNFM24yNWszZVpWeWdpQ05oU3lDcnFlSzR2dV9Td2lza1RFWEd6blAwR3loYURFVjBWUdIBVEFVX3lxTE5FN09CdUFPZWk2X0ZzUE5vR3VwMl9RbzRzZ09ZSjNaMkNuX2NiMjE4cnE3WDJaZGNXeWtCU0pGRnJ2YnBhcHhuVmE0X1B5a0RmdFNIOA?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE94Q29ia2UwSHQyYlpsX0NqRTJRVFZvTjJjZ3lzb0pjUTNFM24yNWszZVpWeWdpQ05oU3lDcnFlSzR2dV9Td2lza1RFWEd6blAwR3loYURFVjBWUdIBVEFVX3lxTE5FN09CdUFPZWk2X0ZzUE5vR3VwMl9RbzRzZ09ZSjNaMkNuX2NiMjE4cnE3WDJaZGNXeWtCU0pGRnJ2YnBhcHhuVmE0X1B5a0RmdFNIOA</guid><pubDate>Mon, 14 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE94Q29ia2UwSHQyYlpsX0NqRTJRVFZvTjJjZ3lzb0pjUTNFM24yNWszZVpWeWdpQ05oU3lDcnFlSzR2dV9Td2lza1RFWEd6blAwR3loYURFVjBWUdIBVEFVX3lxTE5FN09CdUFPZWk2X0ZzUE5vR3VwMl9RbzRzZ09ZSjNaMkNuX2NiMjE4cnE3WDJaZGNXeWtCU0pGRnJ2YnBhcHhuVmE0X1B5a0RmdFNIOA?oc=5" target="_blank"&gt;지투지바이오-베링거인겔하임, 장기지속형 주사제 개발 협력 확대…제형 개발 추가 계약 성사&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>포그바, 약물 징계 끝내고 AS모나코 입단…2년 계약 체결 - 뉴시스</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFA0cWkxWlYtQkhLdnNmY3k5X2dwRzREODc3MDlLaUhrd2JvZUF1TzZuRHUxV18zNmp0eUhFR3pYbW5LY0ZsOVBuS25Gb2hQdWtiZFVETV9pWjhhOFZhYjRQLdIBeEFVX3lxTFBxMlV4QjRVOXRoWkNHdGhEWG5Jc2ZMWXd5TEhXb21zY0NTM2xZNjFfSFl0NUcxTVduN1A3WHBfT09RWEc5WWtIZHozRzlQS2lXOF9mYVUzbUtSejFzbWswelJGa3FSRTlOblZ2Y2cyRFZFbDhBOUpYOQ?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFA0cWkxWlYtQkhLdnNmY3k5X2dwRzREODc3MDlLaUhrd2JvZUF1TzZuRHUxV18zNmp0eUhFR3pYbW5LY0ZsOVBuS25Gb2hQdWtiZFVETV9pWjhhOFZhYjRQLdIBeEFVX3lxTFBxMlV4QjRVOXRoWkNHdGhEWG5Jc2ZMWXd5TEhXb21zY0NTM2xZNjFfSFl0NUcxTVduN1A3WHBfT09RWEc5WWtIZHozRzlQS2lXOF9mYVUzbUtSejFzbWswelJGa3FSRTlOblZ2Y2cyRFZFbDhBOUpYOQ</guid><pubDate>Sun, 29 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFA0cWkxWlYtQkhLdnNmY3k5X2dwRzREODc3MDlLaUhrd2JvZUF1TzZuRHUxV18zNmp0eUhFR3pYbW5LY0ZsOVBuS25Gb2hQdWtiZFVETV9pWjhhOFZhYjRQLdIBeEFVX3lxTFBxMlV4QjRVOXRoWkNHdGhEWG5Jc2ZMWXd5TEhXb21zY0NTM2xZNjFfSFl0NUcxTVduN1A3WHBfT09RWEc5WWtIZHozRzlQS2lXOF9mYVUzbUtSejFzbWswelJGa3FSRTlOblZ2Y2cyRFZFbDhBOUpYOQ?oc=5" target="_blank"&gt;포그바, 약물 징계 끝내고 AS모나코 입단…2년 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴시스&lt;/font&gt;</description><source url="https://www.newsis.com">뉴시스</source></item><item><title>이상훈 에이비엘 대표 "개발중인 이중항체 시나픽스 기술 적용…인투셀 계약 관련 없어" - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTE1nTGNpbk9ObFMtamRrcXJub2IyekR2R0U1YlRZSkR2bkpRU01FNlJIZUs0bkNXWU9XZGVrN2RWck92YWJ0Ump3X2pYS2NpQVZ2UEHSAVNBVV95cUxPQ3lDR0ZQU3YtUzZzdDRYcXVwV2otOHNoOE5hd1pmcDkxNWVqdWVrdUl3VjNnYTRBMTJuN1JBd1M1aXU0WFVMZ2xsU2dXQ3c3TjBSbw?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTE1nTGNpbk9ObFMtamRrcXJub2IyekR2R0U1YlRZSkR2bkpRU01FNlJIZUs0bkNXWU9XZGVrN2RWck92YWJ0Ump3X2pYS2NpQVZ2UEHSAVNBVV95cUxPQ3lDR0ZQU3YtUzZzdDRYcXVwV2otOHNoOE5hd1pmcDkxNWVqdWVrdUl3VjNnYTRBMTJuN1JBd1M1aXU0WFVMZ2xsU2dXQ3c3TjBSbw</guid><pubDate>Thu, 10 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE1nTGNpbk9ObFMtamRrcXJub2IyekR2R0U1YlRZSkR2bkpRU01FNlJIZUs0bkNXWU9XZGVrN2RWck92YWJ0Ump3X2pYS2NpQVZ2UEHSAVNBVV95cUxPQ3lDR0ZQU3YtUzZzdDRYcXVwV2otOHNoOE5hd1pmcDkxNWVqdWVrdUl3VjNnYTRBMTJuN1JBd1M1aXU0WFVMZ2xsU2dXQ3c3TjBSbw?oc=5" target="_blank"&gt;이상훈 에이비엘 대표 "개발중인 이중항체 시나픽스 기술 적용…인투셀 계약 관련 없어"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>'대군부인' 아이유♥변우석, 계약서 유출 후 사면초가...약물테러 자작극 둔갑→왕권 노린다는 루머까지 - 조이뉴스24</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE9MUGhkb09Vc3Y3RHRjNVJ0RkE0di1DdzdoN3NNaVFueUU4NmZZNDdvQWRTWDl0TTRpS1p3eFV6NG01cDRyNm9kdUJ4eEpFbzg?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE9MUGhkb09Vc3Y3RHRjNVJ0RkE0di1DdzdoN3NNaVFueUU4NmZZNDdvQWRTWDl0TTRpS1p3eFV6NG01cDRyNm9kdUJ4eEpFbzg</guid><pubDate>Fri, 08 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9MUGhkb09Vc3Y3RHRjNVJ0RkE0di1DdzdoN3NNaVFueUU4NmZZNDdvQWRTWDl0TTRpS1p3eFV6NG01cDRyNm9kdUJ4eEpFbzg?oc=5" target="_blank"&gt;'대군부인' 아이유♥변우석, 계약서 유출 후 사면초가...약물테러 자작극 둔갑→왕권 노린다는 루머까지&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;조이뉴스24&lt;/font&gt;</description><source url="https://www.joynews24.com">조이뉴스24</source></item><item><title>“복용약 너무 많아”…요양시설 입소자 약물관리 해준다 - 농민신문</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTFBxQTQ3ZjFpa2NTdlBORjZjQmN6ajcybFFTdGtGSHhqTWt5UVRhcWVKMDFHWXNWcmFvRGZMMVFTVGJNdG96OTVYeXlHakRabnJaNHFpSTQxQXp1Zw?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTFBxQTQ3ZjFpa2NTdlBORjZjQmN6ajcybFFTdGtGSHhqTWt5UVRhcWVKMDFHWXNWcmFvRGZMMVFTVGJNdG96OTVYeXlHakRabnJaNHFpSTQxQXp1Zw</guid><pubDate>Tue, 08 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBxQTQ3ZjFpa2NTdlBORjZjQmN6ajcybFFTdGtGSHhqTWt5UVRhcWVKMDFHWXNWcmFvRGZMMVFTVGJNdG96OTVYeXlHakRabnJaNHFpSTQxQXp1Zw?oc=5" target="_blank"&gt;“복용약 너무 많아”…요양시설 입소자 약물관리 해준다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;농민신문&lt;/font&gt;</description><source url="https://www.nongmin.com">농민신문</source></item><item><title>계약서 사인하면서 눈물 펑펑 쏟았다…'약물 징계 해제' 포그바, 모나코 전격 입단 [오피셜] - 네이트</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE5wcTVpN1FIXy1nYmI1YkFXOUhGY3FuR1JjN0ZaenUtd1RTU0tHQXRCWmlIZ0kyanRxaDY4ME13UWlpS2xKZzRiWEpaMlFHRzNydVVXNzZiSXk1bWxE?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE5wcTVpN1FIXy1nYmI1YkFXOUhGY3FuR1JjN0ZaenUtd1RTU0tHQXRCWmlIZ0kyanRxaDY4ME13UWlpS2xKZzRiWEpaMlFHRzNydVVXNzZiSXk1bWxE</guid><pubDate>Sun, 29 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5wcTVpN1FIXy1nYmI1YkFXOUhGY3FuR1JjN0ZaenUtd1RTU0tHQXRCWmlIZ0kyanRxaDY4ME13UWlpS2xKZzRiWEpaMlFHRzNydVVXNzZiSXk1bWxE?oc=5" target="_blank"&gt;계약서 사인하면서 눈물 펑펑 쏟았다…'약물 징계 해제' 포그바, 모나코 전격 입단 [오피셜]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://sports.news.nate.com">네이트</source></item><item><title>[제약+] 신라젠, 베이진과 임상 약물 지원 계약 체결 外 - 딜사이트</title><link>https://news.google.com/rss/articles/CBMiWEFVX3lxTE9fRktHUXdkWFVtbTZnTEh3aW5VWU1XWUNvdU5WN2xKSG9XcTZ6N1BvRGtWOV9Sa3RfMFRrajA2VWpsY1Y3WEFzR3hlU2Z1WjdlV2FTTXhwVzM?oc=5</link><guid isPermaLink="false">CBMiWEFVX3lxTE9fRktHUXdkWFVtbTZnTEh3aW5VWU1XWUNvdU5WN2xKSG9XcTZ6N1BvRGtWOV9Sa3RfMFRrajA2VWpsY1Y3WEFzR3hlU2Z1WjdlV2FTTXhwVzM</guid><pubDate>Tue, 07 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE9fRktHUXdkWFVtbTZnTEh3aW5VWU1XWUNvdU5WN2xKSG9XcTZ6N1BvRGtWOV9Sa3RfMFRrajA2VWpsY1Y3WEFzR3hlU2Z1WjdlV2FTTXhwVzM?oc=5" target="_blank"&gt;[제약+] 신라젠, 베이진과 임상 약물 지원 계약 체결 外&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;딜사이트&lt;/font&gt;</description><source url="https://dealsite.co.kr">딜사이트</source></item><item><title>신라젠, 베이진과 BAL0891 공동개발 계약 체결 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1hSTJ6YW5IWEs0Z1hZU3hLX3gxbnJPUnQ3SUdRMldZSlU3N3FtWDBoem9aX3lUUG5ZdlRnZFhvYUdYc1RBQmhRWnZmSzRGTG41dDNzZi1uUGlOV3lwUS13aTNKS0lDM3UxdVhvd0R3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1hSTJ6YW5IWEs0Z1hZU3hLX3gxbnJPUnQ3SUdRMldZSlU3N3FtWDBoem9aX3lUUG5ZdlRnZFhvYUdYc1RBQmhRWnZmSzRGTG41dDNzZi1uUGlOV3lwUS13aTNKS0lDM3UxdVhvd0R3</guid><pubDate>Tue, 07 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1hSTJ6YW5IWEs0Z1hZU3hLX3gxbnJPUnQ3SUdRMldZSlU3N3FtWDBoem9aX3lUUG5ZdlRnZFhvYUdYc1RBQmhRWnZmSzRGTG41dDNzZi1uUGlOV3lwUS13aTNKS0lDM3UxdVhvd0R3?oc=5" target="_blank"&gt;신라젠, 베이진과 BAL0891 공동개발 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>법원 “기아, 대마초 등 금지약물 한 외국인 선수 계약해지 정당” - 경향신문</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE9QaUluT19fYWNaWnc0U0pyZEpLZlhWbEN5LXBpcHBDR1Y0eXM4c2tEWGo0b25PWW9kSzI3czNaanFqNXk5V2xxa0RLelBDQjB1NmloWW1kN0twd9IBX0FVX3lxTFBCckozaFY4RnNhUnBRMG9WRTB0eDdkaDh5TTZqNHVVVkt1WmtXNklIQzMwcjczazNkVTZ1cE5PWXd3SUJEV2hDMHpxSlFUbGtQenY0RTY2S0h3Q3FleWtj?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE9QaUluT19fYWNaWnc0U0pyZEpLZlhWbEN5LXBpcHBDR1Y0eXM4c2tEWGo0b25PWW9kSzI3czNaanFqNXk5V2xxa0RLelBDQjB1NmloWW1kN0twd9IBX0FVX3lxTFBCckozaFY4RnNhUnBRMG9WRTB0eDdkaDh5TTZqNHVVVkt1WmtXNklIQzMwcjczazNkVTZ1cE5PWXd3SUJEV2hDMHpxSlFUbGtQenY0RTY2S0h3Q3FleWtj</guid><pubDate>Sun, 06 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE9QaUluT19fYWNaWnc0U0pyZEpLZlhWbEN5LXBpcHBDR1Y0eXM4c2tEWGo0b25PWW9kSzI3czNaanFqNXk5V2xxa0RLelBDQjB1NmloWW1kN0twd9IBX0FVX3lxTFBCckozaFY4RnNhUnBRMG9WRTB0eDdkaDh5TTZqNHVVVkt1WmtXNklIQzMwcjczazNkVTZ1cE5PWXd3SUJEV2hDMHpxSlFUbGtQenY0RTY2S0h3Q3FleWtj?oc=5" target="_blank"&gt;법원 “기아, 대마초 등 금지약물 한 외국인 선수 계약해지 정당”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;경향신문&lt;/font&gt;</description><source url="https://www.khan.co.kr">경향신문</source></item><item><title>보령, 박스터와 마취과 약물 2종 국내판권 도입 계약 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTFBaeVA0MWUwc084TW1uMEdlU1paeXhoLUtiUjEwcHg4OXBLcWJEeGU1OElRdFE5c05kY0Z2N2hhUnoyQ3p2R2pvajRaQWVBX2ExbFM2ZFgzckNjTjZq?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTFBaeVA0MWUwc084TW1uMEdlU1paeXhoLUtiUjEwcHg4OXBLcWJEeGU1OElRdFE5c05kY0Z2N2hhUnoyQ3p2R2pvajRaQWVBX2ExbFM2ZFgzckNjTjZq</guid><pubDate>Wed, 10 Jan 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBaeVA0MWUwc084TW1uMEdlU1paeXhoLUtiUjEwcHg4OXBLcWJEeGU1OElRdFE5c05kY0Z2N2hhUnoyQ3p2R2pvajRaQWVBX2ExbFM2ZFgzckNjTjZq?oc=5" target="_blank"&gt;보령, 박스터와 마취과 약물 2종 국내판권 도입 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>삼성바이오에피스-인투셀, ADC 공동연구 계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5QRHZTUE1aZk5pRTRwUmROellxcUVHamc1SGlxNnVwSXRxUHYzY3NROWs5ZW43TnBXTWwtOVEzZnhsdnVhUFRpSDRvQkRWdldxYjNiajJ4LXhvdjNCZ1BzTkktanZEdG9rZS04Zg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5QRHZTUE1aZk5pRTRwUmROellxcUVHamc1SGlxNnVwSXRxUHYzY3NROWs5ZW43TnBXTWwtOVEzZnhsdnVhUFRpSDRvQkRWdldxYjNiajJ4LXhvdjNCZ1BzTkktanZEdG9rZS04Zg</guid><pubDate>Tue, 05 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5QRHZTUE1aZk5pRTRwUmROellxcUVHamc1SGlxNnVwSXRxUHYzY3NROWs5ZW43TnBXTWwtOVEzZnhsdnVhUFRpSDRvQkRWdldxYjNiajJ4LXhvdjNCZ1BzTkktanZEdG9rZS04Zg?oc=5" target="_blank"&gt;삼성바이오에피스-인투셀, ADC 공동연구 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>릴리, 펩트론 SmartDepot 플랫폼에 자사 약물 적용키로 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE16QUpoM21MMXA5SHJnWExfSzN2ZXBGZHcwOHh1UXVjckhzeXdNVVVPLUZfY1ZGUHNBQUY0N0M5ak9lcWllYVBwdEVRUUZyd0xDTUhCNk1IRWVwNXg1dW01eFNpNFEtalJDU29v?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE16QUpoM21MMXA5SHJnWExfSzN2ZXBGZHcwOHh1UXVjckhzeXdNVVVPLUZfY1ZGUHNBQUY0N0M5ak9lcWllYVBwdEVRUUZyd0xDTUhCNk1IRWVwNXg1dW01eFNpNFEtalJDU29v</guid><pubDate>Mon, 07 Oct 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE16QUpoM21MMXA5SHJnWExfSzN2ZXBGZHcwOHh1UXVjckhzeXdNVVVPLUZfY1ZGUHNBQUY0N0M5ak9lcWllYVBwdEVRUUZyd0xDTUhCNk1IRWVwNXg1dW01eFNpNFEtalJDU29v?oc=5" target="_blank"&gt;릴리, 펩트론 SmartDepot 플랫폼에 자사 약물 적용키로&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>펩트론, ‘下’…일라이릴리·카무루스 비만 장기 지속형 약물 전달 계약체결 영향 - 마켓인</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9aNS1DMjlRdWF1eGJJUEtSUGxIOFc3TEFTbWZnd1AxTlpsdm9mV1p1eXd6RjdJUHQ0S1FLc1ZvNzhxNWRqekpEYlhyMzJDYndrN1Y1Y0xDQjNwT2YxeG9fbjBjVTFoT3hVV3dncUFWQ0FOWUk?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9aNS1DMjlRdWF1eGJJUEtSUGxIOFc3TEFTbWZnd1AxTlpsdm9mV1p1eXd6RjdJUHQ0S1FLc1ZvNzhxNWRqekpEYlhyMzJDYndrN1Y1Y0xDQjNwT2YxeG9fbjBjVTFoT3hVV3dncUFWQ0FOWUk</guid><pubDate>Wed, 04 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9aNS1DMjlRdWF1eGJJUEtSUGxIOFc3TEFTbWZnd1AxTlpsdm9mV1p1eXd6RjdJUHQ0S1FLc1ZvNzhxNWRqekpEYlhyMzJDYndrN1Y1Y0xDQjNwT2YxeG9fbjBjVTFoT3hVV3dncUFWQ0FOWUk?oc=5" target="_blank"&gt;펩트론, ‘下’…일라이릴리·카무루스 비만 장기 지속형 약물 전달 계약체결 영향&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;마켓인&lt;/font&gt;</description><source url="https://marketin.edaily.co.kr">마켓인</source></item><item><title>곧 출전 정지 끝나지만…'금지약물' 포그바, 유벤투스와 계약 해지 - 뉴스1</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE5XQmh3TGcyVW4tS1pydjZQaEFINmE1Tnd2RVBGQTRUNVF4V0NUcmlCSENGT2lLd0NwcF9PZG10MW1EbWtySXpIZkRoN0lRc1AtNUllRGt2OFFrQXFORXA2WA?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE5XQmh3TGcyVW4tS1pydjZQaEFINmE1Tnd2RVBGQTRUNVF4V0NUcmlCSENGT2lLd0NwcF9PZG10MW1EbWtySXpIZkRoN0lRc1AtNUllRGt2OFFrQXFORXA2WA</guid><pubDate>Sat, 16 Nov 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5XQmh3TGcyVW4tS1pydjZQaEFINmE1Tnd2RVBGQTRUNVF4V0NUcmlCSENGT2lLd0NwcF9PZG10MW1EbWtySXpIZkRoN0lRc1AtNUllRGt2OFFrQXFORXA2WA?oc=5" target="_blank"&gt;곧 출전 정지 끝나지만…'금지약물' 포그바, 유벤투스와 계약 해지&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스1&lt;/font&gt;</description><source url="https://www.news1.kr">뉴스1</source></item><item><title>알테오젠, MSD와 독점 계약···약물 ‘제형 변경’ 돌풍 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE44N3dUVlZveGliTVNCN1N3WWpsU3ROd0FuTmtRaTlkdzFIUXZKNDEwV1hEWnhqZzhKbDlQNG14YmQxakVfU081VUhiM3BsQkFCdTFPYVBlS3JMQjZqNFFlUXJjVkEyQkhOckZ3VWFLOE1HZ9IBdkFVX3lxTE9lNzlvbFZNSG9SbE9DU01iaGRheFhIWjhNRk9LU1VKSUVyYzJCbHZiSGpFSVJXR3ZYMlR2a0VLY2tYZUEtVS1ydldsWTNhaTNsV0hJc3BtVnZ6VGd1aUgtVEdnYnVMYTlGYV9jdHBVb3pUYThTMGc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE44N3dUVlZveGliTVNCN1N3WWpsU3ROd0FuTmtRaTlkdzFIUXZKNDEwV1hEWnhqZzhKbDlQNG14YmQxakVfU081VUhiM3BsQkFCdTFPYVBlS3JMQjZqNFFlUXJjVkEyQkhOckZ3VWFLOE1HZ9IBdkFVX3lxTE9lNzlvbFZNSG9SbE9DU01iaGRheFhIWjhNRk9LU1VKSUVyYzJCbHZiSGpFSVJXR3ZYMlR2a0VLY2tYZUEtVS1ydldsWTNhaTNsV0hJc3BtVnZ6VGd1aUgtVEdnYnVMYTlGYV9jdHBVb3pUYThTMGc</guid><pubDate>Fri, 23 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE44N3dUVlZveGliTVNCN1N3WWpsU3ROd0FuTmtRaTlkdzFIUXZKNDEwV1hEWnhqZzhKbDlQNG14YmQxakVfU081VUhiM3BsQkFCdTFPYVBlS3JMQjZqNFFlUXJjVkEyQkhOckZ3VWFLOE1HZ9IBdkFVX3lxTE9lNzlvbFZNSG9SbE9DU01iaGRheFhIWjhNRk9LU1VKSUVyYzJCbHZiSGpFSVJXR3ZYMlR2a0VLY2tYZUEtVS1ydldsWTNhaTNsV0hJc3BtVnZ6VGd1aUgtVEdnYnVMYTlGYV9jdHBVb3pUYThTMGc?oc=5" target="_blank"&gt;알테오젠, MSD와 독점 계약···약물 ‘제형 변경’ 돌풍&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>신라젠, 베이진과 ‘임상 약물 지원 계약’ 체결 - 헬스조선</title><link>https://news.google.com/rss/articles/CBMidkFVX3lxTE9ZSElLYzJFMHBPVzJpcENwODFHN0diRzhhakpvVFdHNDRVSlAwQk5tQnhTTmEwdUR0QU9jcGk4YkkwT2pBN2NmcTF3WXpUQVgzUTJGN0dwS3QxVXZnMndFNWg0Wl9XVEZLM19RdnBHVkh0TEJqWGc?oc=5</link><guid isPermaLink="false">CBMidkFVX3lxTE9ZSElLYzJFMHBPVzJpcENwODFHN0diRzhhakpvVFdHNDRVSlAwQk5tQnhTTmEwdUR0QU9jcGk4YkkwT2pBN2NmcTF3WXpUQVgzUTJGN0dwS3QxVXZnMndFNWg0Wl9XVEZLM19RdnBHVkh0TEJqWGc</guid><pubDate>Tue, 07 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9ZSElLYzJFMHBPVzJpcENwODFHN0diRzhhakpvVFdHNDRVSlAwQk5tQnhTTmEwdUR0QU9jcGk4YkkwT2pBN2NmcTF3WXpUQVgzUTJGN0dwS3QxVXZnMndFNWg0Wl9XVEZLM19RdnBHVkh0TEJqWGc?oc=5" target="_blank"&gt;신라젠, 베이진과 ‘임상 약물 지원 계약’ 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스조선&lt;/font&gt;</description><source url="https://m.health.chosun.com">헬스조선</source></item><item><title>‘눈물 펑펑’ 포그바, AS모나코와 2년 계약…약물 징계+친형 협박 사건 끝에 2년 만에 현역 복귀 - sports.donga.com</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE9qbjBzN0drR01ScEdtN3ZQSTRDYnZmaEg2NzVMems0dlAyV05PV2J0QllSN1RDLUk0MjU2UkFadXh0U0NQVW9sYktRQk8zekE1bGd1ZlZxdkdOU0VOb0R3aGd1ZGVjdDZidVZ6cXdpUkVnZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE9qbjBzN0drR01ScEdtN3ZQSTRDYnZmaEg2NzVMems0dlAyV05PV2J0QllSN1RDLUk0MjU2UkFadXh0U0NQVW9sYktRQk8zekE1bGd1ZlZxdkdOU0VOb0R3aGd1ZGVjdDZidVZ6cXdpUkVnZw</guid><pubDate>Sun, 29 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9qbjBzN0drR01ScEdtN3ZQSTRDYnZmaEg2NzVMems0dlAyV05PV2J0QllSN1RDLUk0MjU2UkFadXh0U0NQVW9sYktRQk8zekE1bGd1ZlZxdkdOU0VOb0R3aGd1ZGVjdDZidVZ6cXdpUkVnZw?oc=5" target="_blank"&gt;‘눈물 펑펑’ 포그바, AS모나코와 2년 계약…약물 징계+친형 협박 사건 끝에 2년 만에 현역 복귀&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;sports.donga.com&lt;/font&gt;</description><source url="https://sports.donga.com">sports.donga.com</source></item><item><title>온코크로스, 이르면 내년 분기 BEP 도달…리커전 넘어설 경쟁력은? - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE5WUkdEQ2FrZ0FsMW54OEpnUnFTVUllOTRrWDV3LXRmSGlDUXVlWGY0R1JZLUUyX0VWcGhEV0VjYlJkTU14X1FTNWd6WnVpU21PUktYLXphOVVGcmpibE94d1Q0UGpIVC1YZWxfNkxn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE5WUkdEQ2FrZ0FsMW54OEpnUnFTVUllOTRrWDV3LXRmSGlDUXVlWGY0R1JZLUUyX0VWcGhEV0VjYlJkTU14X1FTNWd6WnVpU21PUktYLXphOVVGcmpibE94d1Q0UGpIVC1YZWxfNkxn</guid><pubDate>Mon, 07 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5WUkdEQ2FrZ0FsMW54OEpnUnFTVUllOTRrWDV3LXRmSGlDUXVlWGY0R1JZLUUyX0VWcGhEV0VjYlJkTU14X1FTNWd6WnVpU21PUktYLXphOVVGcmpibE94d1Q0UGpIVC1YZWxfNkxn?oc=5" target="_blank"&gt;온코크로스, 이르면 내년 분기 BEP 도달…리커전 넘어설 경쟁력은?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>일라이 릴리(LLY.N), 제네틱 립과 계약…독자적 RNA 기반 약물 개발 - 알파경제</title><link>https://news.google.com/rss/articles/CBMiXkFVX3lxTE4wSVpjcUc3Umo4MXBsMXhNci1zaFJycUk1bEFqN1dRSDlvWHQ5QnVsQnpuYU11ZjNoRW9iNWtIZlc4VDNOZzRuZE1KLUN2d1ZGN0N0SHdveWdjUVdJUHfSAW5BVV95cUxPUHdMTUxJNnJoMXoyLUExTmFrZzc4Q2RJTmw4R09FNWpkRXJmSFZBRzV1c2RBM1F6dlRBZlJ0cDhJZlRCX1lzb3V0RkFlT2oxTUhYQi1lSGd1VXJkdkZEU1dPMy1SQkdXZUR2UElwdw?oc=5</link><guid isPermaLink="false">CBMiXkFVX3lxTE4wSVpjcUc3Umo4MXBsMXhNci1zaFJycUk1bEFqN1dRSDlvWHQ5QnVsQnpuYU11ZjNoRW9iNWtIZlc4VDNOZzRuZE1KLUN2d1ZGN0N0SHdveWdjUVdJUHfSAW5BVV95cUxPUHdMTUxJNnJoMXoyLUExTmFrZzc4Q2RJTmw4R09FNWpkRXJmSFZBRzV1c2RBM1F6dlRBZlJ0cDhJZlRCX1lzb3V0RkFlT2oxTUhYQi1lSGd1VXJkdkZEU1dPMy1SQkdXZUR2UElwdw</guid><pubDate>Fri, 06 Sep 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE4wSVpjcUc3Umo4MXBsMXhNci1zaFJycUk1bEFqN1dRSDlvWHQ5QnVsQnpuYU11ZjNoRW9iNWtIZlc4VDNOZzRuZE1KLUN2d1ZGN0N0SHdveWdjUVdJUHfSAW5BVV95cUxPUHdMTUxJNnJoMXoyLUExTmFrZzc4Q2RJTmw4R09FNWpkRXJmSFZBRzV1c2RBM1F6dlRBZlJ0cDhJZlRCX1lzb3V0RkFlT2oxTUhYQi1lSGd1VXJkdkZEU1dPMy1SQkdXZUR2UElwdw?oc=5" target="_blank"&gt;일라이 릴리(LLY.N), 제네틱 립과 계약…독자적 RNA 기반 약물 개발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;알파경제&lt;/font&gt;</description><source url="https://alphabiz.co.kr">알파경제</source></item><item><title>美 사렙타, 나이벡 약물전달 기술력 인정 ‘MTA확대 계약, 공동연구 수준 협력관계’ - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1uakVmWG96Nk0tR0NWemlOVXlmNGRYWEo5R3IyUFpaNnk4V2MyN3JiQ2xja0N1T0JkaU00bXNBeTlSUU9abWhqMHFLd0UxaXhMOExHa1dKNDQtSFVZbUsxNUh1azJINWtLY3NURQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1uakVmWG96Nk0tR0NWemlOVXlmNGRYWEo5R3IyUFpaNnk4V2MyN3JiQ2xja0N1T0JkaU00bXNBeTlSUU9abWhqMHFLd0UxaXhMOExHa1dKNDQtSFVZbUsxNUh1azJINWtLY3NURQ</guid><pubDate>Thu, 24 Oct 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1uakVmWG96Nk0tR0NWemlOVXlmNGRYWEo5R3IyUFpaNnk4V2MyN3JiQ2xja0N1T0JkaU00bXNBeTlSUU9abWhqMHFLd0UxaXhMOExHa1dKNDQtSFVZbUsxNUh1azJINWtLY3NURQ?oc=5" target="_blank"&gt;美 사렙타, 나이벡 약물전달 기술력 인정 ‘MTA확대 계약, 공동연구 수준 협력관계’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>펩트론, 일라이 릴리와 손잡고 펩타이드 약물 연구 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1oRFhjQzR5T0duSjF5NzdwX01XYlVOZkQzN0lQN3dqYnNXZHJiVEFXMzR2Y0tRVk5ib3JaRFE3SWs5S284T19NV1JPeUNCa1dvNTR3M3ZiTnpoN01MM1l1c1MtTlZ5TF9JWTNIMXEzTdIBc0FVX3lxTE4zWlpMWk5ydUVmdGpvVzRXQ2FGcEFrUFFzVHFFZDVFMlUzUVQ1Nk9JT19MSTA1eUlIdWNnUEs2WEg5dWlGU1N3NUNfVnVncG5oSGx3Q29HTEw3WlJ2QTdiekxpMnMtUThXQjc3ZDJzU2RMTWs?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1oRFhjQzR5T0duSjF5NzdwX01XYlVOZkQzN0lQN3dqYnNXZHJiVEFXMzR2Y0tRVk5ib3JaRFE3SWs5S284T19NV1JPeUNCa1dvNTR3M3ZiTnpoN01MM1l1c1MtTlZ5TF9JWTNIMXEzTdIBc0FVX3lxTE4zWlpMWk5ydUVmdGpvVzRXQ2FGcEFrUFFzVHFFZDVFMlUzUVQ1Nk9JT19MSTA1eUlIdWNnUEs2WEg5dWlGU1N3NUNfVnVncG5oSGx3Q29HTEw3WlJ2QTdiekxpMnMtUThXQjc3ZDJzU2RMTWs</guid><pubDate>Tue, 08 Oct 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1oRFhjQzR5T0duSjF5NzdwX01XYlVOZkQzN0lQN3dqYnNXZHJiVEFXMzR2Y0tRVk5ib3JaRFE3SWs5S284T19NV1JPeUNCa1dvNTR3M3ZiTnpoN01MM1l1c1MtTlZ5TF9JWTNIMXEzTdIBc0FVX3lxTE4zWlpMWk5ydUVmdGpvVzRXQ2FGcEFrUFFzVHFFZDVFMlUzUVQ1Nk9JT19MSTA1eUlIdWNnUEs2WEg5dWlGU1N3NUNfVnVncG5oSGx3Q29HTEw3WlJ2QTdiekxpMnMtUThXQjc3ZDJzU2RMTWs?oc=5" target="_blank"&gt;펩트론, 일라이 릴리와 손잡고 펩타이드 약물 연구&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>나이벡, 美 바이오 社 mRNA 신약 파이프라인 70% 약물전달 입증 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBqLXZmRWNxNjdfMENaRU03eUk0bjY5RGtSbmhGdHViTE81YXNGZm8wUUlWWlMyYU1SWXl0RWhJLUVrZmloTUNjbkZ1N3l1QzV3X2tfUjNrLXdVMmF2Um9YVDYwS3FsSWI3WkEyNQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBqLXZmRWNxNjdfMENaRU03eUk0bjY5RGtSbmhGdHViTE81YXNGZm8wUUlWWlMyYU1SWXl0RWhJLUVrZmloTUNjbkZ1N3l1QzV3X2tfUjNrLXdVMmF2Um9YVDYwS3FsSWI3WkEyNQ</guid><pubDate>Tue, 29 Oct 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBqLXZmRWNxNjdfMENaRU03eUk0bjY5RGtSbmhGdHViTE81YXNGZm8wUUlWWlMyYU1SWXl0RWhJLUVrZmloTUNjbkZ1N3l1QzV3X2tfUjNrLXdVMmF2Um9YVDYwS3FsSWI3WkEyNQ?oc=5" target="_blank"&gt;나이벡, 美 바이오 社 mRNA 신약 파이프라인 70% 약물전달 입증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>GC녹십자, 카나프와 이중항체 ADC공동개발 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFAwVkx3cERKUEZIZFdKSmdxbXd1cUNUcUItWW56YVZ6ODlDYi1DdzNpZDVTSWFpWFVQZERYd0FIelg4YzBWWnlULTBqYk4xS0g1NGVvNmFJNFJXenFfWHFsTEs5RFI2dGNoM0Z3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFAwVkx3cERKUEZIZFdKSmdxbXd1cUNUcUItWW56YVZ6ODlDYi1DdzNpZDVTSWFpWFVQZERYd0FIelg4YzBWWnlULTBqYk4xS0g1NGVvNmFJNFJXenFfWHFsTEs5RFI2dGNoM0Z3</guid><pubDate>Fri, 22 Nov 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFAwVkx3cERKUEZIZFdKSmdxbXd1cUNUcUItWW56YVZ6ODlDYi1DdzNpZDVTSWFpWFVQZERYd0FIelg4YzBWWnlULTBqYk4xS0g1NGVvNmFJNFJXenFfWHFsTEs5RFI2dGNoM0Z3?oc=5" target="_blank"&gt;GC녹십자, 카나프와 이중항체 ADC공동개발 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>지투지바이오, 베링거와 '장기지속 제형개발' 연구계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFAwc1h3TndiV2lhRlNNMlg5Q0trM2ZUVUtCY2ZGLTJhcURSb1ptUEhNSWRSVGo1RFFLMTRVWlBPQXR4OXJyMkJXUlhKTVVxY2xzZlF6NnctMA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFAwc1h3TndiV2lhRlNNMlg5Q0trM2ZUVUtCY2ZGLTJhcURSb1ptUEhNSWRSVGo1RFFLMTRVWlBPQXR4OXJyMkJXUlhKTVVxY2xzZlF6NnctMA</guid><pubDate>Fri, 07 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFAwc1h3TndiV2lhRlNNMlg5Q0trM2ZUVUtCY2ZGLTJhcURSb1ptUEhNSWRSVGo1RFFLMTRVWlBPQXR4OXJyMkJXUlhKTVVxY2xzZlF6NnctMA?oc=5" target="_blank"&gt;지투지바이오, 베링거와 '장기지속 제형개발' 연구계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>빅파마 4개사, 펩트론 약물전달 플랫폼에 러브콜 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxQOHBuVmpidDc4VE1JakQ4MThxUUsxWnc0UGFWTkFlREZkZnhFVjF6SW42YXJROWdtSGhtTjhjRlBRM3hQbld0SmhqZlBvWG84ZDB4SlpuWUVjVmNlaWZMay1kOGF0cXRfRENBelNpRFJZSWJJWWFWQkhTSDV5cFhBem1CVQ?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxQOHBuVmpidDc4VE1JakQ4MThxUUsxWnc0UGFWTkFlREZkZnhFVjF6SW42YXJROWdtSGhtTjhjRlBRM3hQbld0SmhqZlBvWG84ZDB4SlpuWUVjVmNlaWZMay1kOGF0cXRfRENBelNpRFJZSWJJWWFWQkhTSDV5cFhBem1CVQ</guid><pubDate>Fri, 24 May 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQOHBuVmpidDc4VE1JakQ4MThxUUsxWnc0UGFWTkFlREZkZnhFVjF6SW42YXJROWdtSGhtTjhjRlBRM3hQbld0SmhqZlBvWG84ZDB4SlpuWUVjVmNlaWZMay1kOGF0cXRfRENBelNpRFJZSWJJWWFWQkhTSDV5cFhBem1CVQ?oc=5" target="_blank"&gt;빅파마 4개사, 펩트론 약물전달 플랫폼에 러브콜&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>이 정도면 사기 계약, 618억 FA 투자했는데…약물로 만든 커리어하이, 헛돈 안 쓰는 팀이 봉변 당했다 - 조선일보</title><link>https://news.google.com/rss/articles/CBMiiwFBVV95cUxOemxVaDNvQTZCRHB0OEtla1JzUGVycm9vMEY0NVhINGxDUk51V2toclJWRTJpODBiNEc0LUVxX0NCZGVYNnZxUGh2UDNEZUc2a3FPU1duYnNlVTBBWW5jdnBFME90MWprelRqdnBUdlczTkpYRkk5dnlNWkRNaHNEMEdyX2NuaDZtZGxr?oc=5</link><guid isPermaLink="false">CBMiiwFBVV95cUxOemxVaDNvQTZCRHB0OEtla1JzUGVycm9vMEY0NVhINGxDUk51V2toclJWRTJpODBiNEc0LUVxX0NCZGVYNnZxUGh2UDNEZUc2a3FPU1duYnNlVTBBWW5jdnBFME90MWprelRqdnBUdlczTkpYRkk5dnlNWkRNaHNEMEdyX2NuaDZtZGxr</guid><pubDate>Wed, 02 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOemxVaDNvQTZCRHB0OEtla1JzUGVycm9vMEY0NVhINGxDUk51V2toclJWRTJpODBiNEc0LUVxX0NCZGVYNnZxUGh2UDNEZUc2a3FPU1duYnNlVTBBWW5jdnBFME90MWprelRqdnBUdlczTkpYRkk5dnlNWkRNaHNEMEdyX2NuaDZtZGxr?oc=5" target="_blank"&gt;이 정도면 사기 계약, 618억 FA 투자했는데…약물로 만든 커리어하이, 헛돈 안 쓰는 팀이 봉변 당했다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;조선일보&lt;/font&gt;</description><source url="https://www.chosun.com">조선일보</source></item><item><title>펩트론, LG화학과 ‘루프린 제네릭’ 국내판권 계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1TaWxJNVJRMVd5dW0tOXBhaVZESmlncUozWVdaZS05NE5ZdUtKYkRWNTJfY01TaEtMYUE5dEVRQm40dnA0VlFjZWR0THA0UGtVb0IzZFBGNVVOSmlkaHNIQ0wyM1ppcnB6bWVzbg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1TaWxJNVJRMVd5dW0tOXBhaVZESmlncUozWVdaZS05NE5ZdUtKYkRWNTJfY01TaEtMYUE5dEVRQm40dnA0VlFjZWR0THA0UGtVb0IzZFBGNVVOSmlkaHNIQ0wyM1ppcnB6bWVzbg</guid><pubDate>Mon, 13 Nov 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1TaWxJNVJRMVd5dW0tOXBhaVZESmlncUozWVdaZS05NE5ZdUtKYkRWNTJfY01TaEtMYUE5dEVRQm40dnA0VlFjZWR0THA0UGtVb0IzZFBGNVVOSmlkaHNIQ0wyM1ppcnB6bWVzbg?oc=5" target="_blank"&gt;펩트론, LG화학과 ‘루프린 제네릭’ 국내판권 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>신라젠, 베이진과 임상 약물 지원 계약 체결 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9xaDBPTnlvdEZraWlPQWZRYjk0SFNwWkplVHVSTVdwR1B0MVJnLW16M0dLWFluamJqZGpBbmJlT19Fd3FkVkpqUHctVnpBeVBTSmw2YlRqWnU5NjJUY005VlV4UmR1ZG9FTkE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9xaDBPTnlvdEZraWlPQWZRYjk0SFNwWkplVHVSTVdwR1B0MVJnLW16M0dLWFluamJqZGpBbmJlT19Fd3FkVkpqUHctVnpBeVBTSmw2YlRqWnU5NjJUY005VlV4UmR1ZG9FTkE</guid><pubDate>Tue, 07 Jan 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9xaDBPTnlvdEZraWlPQWZRYjk0SFNwWkplVHVSTVdwR1B0MVJnLW16M0dLWFluamJqZGpBbmJlT19Fd3FkVkpqUHctVnpBeVBTSmw2YlRqWnU5NjJUY005VlV4UmR1ZG9FTkE?oc=5" target="_blank"&gt;신라젠, 베이진과 임상 약물 지원 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>삼일-CMG, 필름형 편두통 치료제 '나라필 ODF' 파트너 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE15T2N3OWw1TGlyREYxU190V2N3QkpKbVJ6SXVTODIwTkF4SlFxb0JiVW1STUV6cnlEUnllY1pKY3NmOWhJN19RcmNHLU5KaHB5N19ya3dhb0JPX2F5SEcxWmlYRVB3ak5hcUpZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE15T2N3OWw1TGlyREYxU190V2N3QkpKbVJ6SXVTODIwTkF4SlFxb0JiVW1STUV6cnlEUnllY1pKY3NmOWhJN19RcmNHLU5KaHB5N19ya3dhb0JPX2F5SEcxWmlYRVB3ak5hcUpZ</guid><pubDate>Tue, 18 Jun 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE15T2N3OWw1TGlyREYxU190V2N3QkpKbVJ6SXVTODIwTkF4SlFxb0JiVW1STUV6cnlEUnllY1pKY3NmOWhJN19RcmNHLU5KaHB5N19ya3dhb0JPX2F5SEcxWmlYRVB3ak5hcUpZ?oc=5" target="_blank"&gt;삼일-CMG, 필름형 편두통 치료제 '나라필 ODF' 파트너 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>대웅제약, '월1회' 세마글루타이드 "공동개발 계약" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE95OXk5RlRsdGNkX0tjdFJSVUtNSkRqMG9MODdpWXVwUHJvS25NZmpPc0dzS2pOQUU2QXg0bUkzNWM0dFY2LVhvdWhtVFlHa3VwVVJja3lmYjIwdUZhclBnT3haa3NEUlJpTmNrSw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE95OXk5RlRsdGNkX0tjdFJSVUtNSkRqMG9MODdpWXVwUHJvS25NZmpPc0dzS2pOQUU2QXg0bUkzNWM0dFY2LVhvdWhtVFlHa3VwVVJja3lmYjIwdUZhclBnT3haa3NEUlJpTmNrSw</guid><pubDate>Thu, 12 Dec 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE95OXk5RlRsdGNkX0tjdFJSVUtNSkRqMG9MODdpWXVwUHJvS25NZmpPc0dzS2pOQUU2QXg0bUkzNWM0dFY2LVhvdWhtVFlHa3VwVVJja3lmYjIwdUZhclBnT3haa3NEUlJpTmNrSw?oc=5" target="_blank"&gt;대웅제약, '월1회' 세마글루타이드 "공동개발 계약"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>업테라, 보령과 다발성골수종 TPD “공동개발 계약” - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5CYUhVaEhFRDRtbkMwV2NkT0ZlNExTc0hhXzNxTkpFS3JEblVFZTBHbkVCaFFSRnVNdUpkU0daOEtlaUd5QUNLWTExWkJ5LTN3bGFRTUV6MHg5UWNmTGtDTlloZkkzRmFwTU5jbg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5CYUhVaEhFRDRtbkMwV2NkT0ZlNExTc0hhXzNxTkpFS3JEblVFZTBHbkVCaFFSRnVNdUpkU0daOEtlaUd5QUNLWTExWkJ5LTN3bGFRTUV6MHg5UWNmTGtDTlloZkkzRmFwTU5jbg</guid><pubDate>Wed, 25 Jan 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5CYUhVaEhFRDRtbkMwV2NkT0ZlNExTc0hhXzNxTkpFS3JEblVFZTBHbkVCaFFSRnVNdUpkU0daOEtlaUd5QUNLWTExWkJ5LTN3bGFRTUV6MHg5UWNmTGtDTlloZkkzRmFwTU5jbg?oc=5" target="_blank"&gt;업테라, 보령과 다발성골수종 TPD “공동개발 계약”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>론자, 앱티스와 항체-약물접합체(ADC) 기술협력 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBONEMxVWUxZXdOcGtvWUFzblU2WGEzOV9lRTdfaGp2eVNRcUhqcnp6NHFDRkUzMjduZ3ZKSGRNY0pXRkxNUGREWHRqMDFKQmlnMDYzNmoyN0NneGNENWxySGJVc3hVUjhLUWc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBONEMxVWUxZXdOcGtvWUFzblU2WGEzOV9lRTdfaGp2eVNRcUhqcnp6NHFDRkUzMjduZ3ZKSGRNY0pXRkxNUGREWHRqMDFKQmlnMDYzNmoyN0NneGNENWxySGJVc3hVUjhLUWc</guid><pubDate>Wed, 07 Dec 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBONEMxVWUxZXdOcGtvWUFzblU2WGEzOV9lRTdfaGp2eVNRcUhqcnp6NHFDRkUzMjduZ3ZKSGRNY0pXRkxNUGREWHRqMDFKQmlnMDYzNmoyN0NneGNENWxySGJVc3hVUjhLUWc?oc=5" target="_blank"&gt;론자, 앱티스와 항체-약물접합체(ADC) 기술협력 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>신테카바이오, 한미와 계약 유지 주장하지만...불확실성 'UP' - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxNT2RnREN3ZjZwa1dZbHF3UVItRWFVREI0YzBQNWRUZF92SVYyMERXT1pUbU5ITUdrR2w5amRzZkRZb0FzelFVM29BOURKQml2ZEtRaXVOZVdTU0xTYXl3MU50WGtocHpjdTF6T1M4UnUzNVBkY01tYXU5ZTJpalE2LVN2NA?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxNT2RnREN3ZjZwa1dZbHF3UVItRWFVREI0YzBQNWRUZF92SVYyMERXT1pUbU5ITUdrR2w5amRzZkRZb0FzelFVM29BOURKQml2ZEtRaXVOZVdTU0xTYXl3MU50WGtocHpjdTF6T1M4UnUzNVBkY01tYXU5ZTJpalE2LVN2NA</guid><pubDate>Thu, 09 Feb 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNT2RnREN3ZjZwa1dZbHF3UVItRWFVREI0YzBQNWRUZF92SVYyMERXT1pUbU5ITUdrR2w5amRzZkRZb0FzelFVM29BOURKQml2ZEtRaXVOZVdTU0xTYXl3MU50WGtocHpjdTF6T1M4UnUzNVBkY01tYXU5ZTJpalE2LVN2NA?oc=5" target="_blank"&gt;신테카바이오, 한미와 계약 유지 주장하지만...불확실성 'UP'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>삼성바이오에피스·인투셀, 항체-약물 접합체 공동연구 계약 체결 - 지디넷코리아</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE53a1VXcHprOVNMM2hBMGhIeE1Kc0lITUplM0pzMjNySkJrXzlzZGxQTzMxY3Bnamphak5fc1YyVzJablVDYXdIODBacHBrOU1Sd2xlYWdB?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE53a1VXcHprOVNMM2hBMGhIeE1Kc0lITUplM0pzMjNySkJrXzlzZGxQTzMxY3Bnamphak5fc1YyVzJablVDYXdIODBacHBrOU1Sd2xlYWdB</guid><pubDate>Tue, 05 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE53a1VXcHprOVNMM2hBMGhIeE1Kc0lITUplM0pzMjNySkJrXzlzZGxQTzMxY3Bnamphak5fc1YyVzJablVDYXdIODBacHBrOU1Sd2xlYWdB?oc=5" target="_blank"&gt;삼성바이오에피스·인투셀, 항체-약물 접합체 공동연구 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;지디넷코리아&lt;/font&gt;</description><source url="https://zdnet.co.kr">지디넷코리아</source></item><item><title>HLB, 항서제약 '캄렐리주맙' 간암부문 글로벌 판권 인수계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9Zc0E4VVVORlQyQ0xKeDR4RTJVREIwQlBpeEVrbnA5akQ0UldNQzBDaUc4QzZWMlU1RG9pU0l3VGVlVGhvbDdEejJtbkdxeElScXlBbW5iNWZZeDNYeEpOa3Jvam1NZE9JVzAw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9Zc0E4VVVORlQyQ0xKeDR4RTJVREIwQlBpeEVrbnA5akQ0UldNQzBDaUc4QzZWMlU1RG9pU0l3VGVlVGhvbDdEejJtbkdxeElScXlBbW5iNWZZeDNYeEpOa3Jvam1NZE9JVzAw</guid><pubDate>Tue, 17 Oct 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9Zc0E4VVVORlQyQ0xKeDR4RTJVREIwQlBpeEVrbnA5akQ0UldNQzBDaUc4QzZWMlU1RG9pU0l3VGVlVGhvbDdEejJtbkdxeElScXlBbW5iNWZZeDNYeEpOa3Jvam1NZE9JVzAw?oc=5" target="_blank"&gt;HLB, 항서제약 '캄렐리주맙' 간암부문 글로벌 판권 인수계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>‘금지 약물 복용 이슈’ AS 모나코와 2년 계약 합의...사우디아라비아 오일 머니 거절 - stnsports.co.kr</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1fb0o2OC1MU1hSbjdTaWdQU2ZQcXNBWTU3cG90d2M0S29pNWY3eXRMNy1Xd1FhMmQ4Ymw3QTJzUHN3YmU0VTlRdXdWbXpxV1dKNFZuMFFJbDdoZTE5VEQwUWJxc0FTUWJmZ1c4ZGxtNA?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1fb0o2OC1MU1hSbjdTaWdQU2ZQcXNBWTU3cG90d2M0S29pNWY3eXRMNy1Xd1FhMmQ4Ymw3QTJzUHN3YmU0VTlRdXdWbXpxV1dKNFZuMFFJbDdoZTE5VEQwUWJxc0FTUWJmZ1c4ZGxtNA</guid><pubDate>Mon, 23 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1fb0o2OC1MU1hSbjdTaWdQU2ZQcXNBWTU3cG90d2M0S29pNWY3eXRMNy1Xd1FhMmQ4Ymw3QTJzUHN3YmU0VTlRdXdWbXpxV1dKNFZuMFFJbDdoZTE5VEQwUWJxc0FTUWJmZ1c4ZGxtNA?oc=5" target="_blank"&gt;‘금지 약물 복용 이슈’ AS 모나코와 2년 계약 합의...사우디아라비아 오일 머니 거절&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;stnsports.co.kr&lt;/font&gt;</description><source url="https://www.stnsports.co.kr">stnsports.co.kr</source></item><item><title>종근당, 네덜란드 시나픽스와 ADC 기술 도입 계약 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5ZZjNtajdJcE50Ry1qeW9CZVBzMUJjaVlYcGhETnF4bVlpLUxHZjI2NzdBRm1ocHBPT3phNmlzOTJUbzVJd0F2MGV1UmRSSmF2Sm1FM1RyVG5IQ19fdERVX0RmQzlrNkc2MGVZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5ZZjNtajdJcE50Ry1qeW9CZVBzMUJjaVlYcGhETnF4bVlpLUxHZjI2NzdBRm1ocHBPT3phNmlzOTJUbzVJd0F2MGV1UmRSSmF2Sm1FM1RyVG5IQ19fdERVX0RmQzlrNkc2MGVZ</guid><pubDate>Mon, 06 Feb 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5ZZjNtajdJcE50Ry1qeW9CZVBzMUJjaVlYcGhETnF4bVlpLUxHZjI2NzdBRm1ocHBPT3phNmlzOTJUbzVJd0F2MGV1UmRSSmF2Sm1FM1RyVG5IQ19fdERVX0RmQzlrNkc2MGVZ?oc=5" target="_blank"&gt;종근당, 네덜란드 시나픽스와 ADC 기술 도입 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>릴리, 슈뢰딩거와 'AI 약물발굴' 4.25억弗 딜 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE90cHJHWTR6aDZCLWZIMzFPb2dTZDZqREl4ZWNKRndnelJPclktNHpWN0l3aXZyRjkwR3dhTzJnLWNxc3FPbGlSbDFOX1hRMElGWGVMU3JXM2tGYk9iejZLZXFRNTczbE90ZjZOcQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE90cHJHWTR6aDZCLWZIMzFPb2dTZDZqREl4ZWNKRndnelJPclktNHpWN0l3aXZyRjkwR3dhTzJnLWNxc3FPbGlSbDFOX1hRMElGWGVMU3JXM2tGYk9iejZLZXFRNTczbE90ZjZOcQ</guid><pubDate>Mon, 10 Oct 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE90cHJHWTR6aDZCLWZIMzFPb2dTZDZqREl4ZWNKRndnelJPclktNHpWN0l3aXZyRjkwR3dhTzJnLWNxc3FPbGlSbDFOX1hRMElGWGVMU3JXM2tGYk9iejZLZXFRNTczbE90ZjZOcQ?oc=5" target="_blank"&gt;릴리, 슈뢰딩거와 'AI 약물발굴' 4.25억弗 딜&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>브릿지바이오, 브레이노믹스와 "AI 약물분석 계약" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE1OTXI4N2lHVHpsSlk2U2h5RWtTN2loQWkzVTJEeEtLd0lOaVhxaVlWTm5uanhaeUF5ZmJDS1MxRW1nQnRCdktjTEIzZlBDSjZkMF9mcURSOA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE1OTXI4N2lHVHpsSlk2U2h5RWtTN2loQWkzVTJEeEtLd0lOaVhxaVlWTm5uanhaeUF5ZmJDS1MxRW1nQnRCdktjTEIzZlBDSjZkMF9mcURSOA</guid><pubDate>Tue, 06 Sep 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1OTXI4N2lHVHpsSlk2U2h5RWtTN2loQWkzVTJEeEtLd0lOaVhxaVlWTm5uanhaeUF5ZmJDS1MxRW1nQnRCdktjTEIzZlBDSjZkMF9mcURSOA?oc=5" target="_blank"&gt;브릿지바이오, 브레이노믹스와 "AI 약물분석 계약"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>[창간기획]라이선스 딜에서 ‘계약금(upfront)’ 의미는? - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE54SVBJbnRxMTFmSzRvU0E4NS16ZUtBXzE4Y1ZMV21MUGV6M1FjU3B5SE53Nzd2VU5oTGpLMk9pQkpHeXZYOVhad1YxN0lwTGJVSnlvaDJxWUpaVkpWeUh2V1dsVTdhX1Q1UEY1Vw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE54SVBJbnRxMTFmSzRvU0E4NS16ZUtBXzE4Y1ZMV21MUGV6M1FjU3B5SE53Nzd2VU5oTGpLMk9pQkpHeXZYOVhad1YxN0lwTGJVSnlvaDJxWUpaVkpWeUh2V1dsVTdhX1Q1UEY1Vw</guid><pubDate>Thu, 17 Jun 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE54SVBJbnRxMTFmSzRvU0E4NS16ZUtBXzE4Y1ZMV21MUGV6M1FjU3B5SE53Nzd2VU5oTGpLMk9pQkpHeXZYOVhad1YxN0lwTGJVSnlvaDJxWUpaVkpWeUh2V1dsVTdhX1Q1UEY1Vw?oc=5" target="_blank"&gt;[창간기획]라이선스 딜에서 ‘계약금(upfront)’ 의미는?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://m.biospectator.com">바이오스펙테이터</source></item><item><title>SK플라즈마, 에임드바이오와 ADC 항암 신약 공동개발·라이선스 계약 체결 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE5yMDl1V0MzQmF5Sl95Y2NiNVlNMWVPRnRQRlRRZWVlWEhZWURKMjhQQlBraHI2WUk0aWR4Q2RuVXZfLXRRY3Vab2MwNTZheW9SajdENGxsUkxVcXdOdnE5TWNkblRyTFQwanlMWU5R?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE5yMDl1V0MzQmF5Sl95Y2NiNVlNMWVPRnRQRlRRZWVlWEhZWURKMjhQQlBraHI2WUk0aWR4Q2RuVXZfLXRRY3Vab2MwNTZheW9SajdENGxsUkxVcXdOdnE5TWNkblRyTFQwanlMWU5R</guid><pubDate>Mon, 09 Jun 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5yMDl1V0MzQmF5Sl95Y2NiNVlNMWVPRnRQRlRRZWVlWEhZWURKMjhQQlBraHI2WUk0aWR4Q2RuVXZfLXRRY3Vab2MwNTZheW9SajdENGxsUkxVcXdOdnE5TWNkblRyTFQwanlMWU5R?oc=5" target="_blank"&gt;SK플라즈마, 에임드바이오와 ADC 항암 신약 공동개발·라이선스 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>10억달러 이상 라이선스 계약 5건 중 1건은 ADC, 빅파마 관심 높은 분야는 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE9renVCTjRxWHdna1V6SFU0UXAyUE15VGlEWUwyLTNtc3M2Vjhmd1BpSV9XT2V6NzhpNGZlYTc2OWZHSFYwbjEzOXZseWo3aV9LMTV3Nw?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE9renVCTjRxWHdna1V6SFU0UXAyUE15VGlEWUwyLTNtc3M2Vjhmd1BpSV9XT2V6NzhpNGZlYTc2OWZHSFYwbjEzOXZseWo3aV9LMTV3Nw</guid><pubDate>Mon, 10 Jul 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9renVCTjRxWHdna1V6SFU0UXAyUE15VGlEWUwyLTNtc3M2Vjhmd1BpSV9XT2V6NzhpNGZlYTc2OWZHSFYwbjEzOXZseWo3aV9LMTV3Nw?oc=5" target="_blank"&gt;10억달러 이상 라이선스 계약 5건 중 1건은 ADC, 빅파마 관심 높은 분야는&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://m.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>엠디뮨-美엑소나노RNA, 표적 약물전달 공동연구 계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE5fZXU2SDR3cWxReG9rNGNuSGFITkNBMXdFZ2FhSmFPYm1UTW9WYzVKck1fYkhLMHRKNG43VXRZN2FxbnZmNzRHWHpucktmOE5qS0FLTXNtTQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE5fZXU2SDR3cWxReG9rNGNuSGFITkNBMXdFZ2FhSmFPYm1UTW9WYzVKck1fYkhLMHRKNG43VXRZN2FxbnZmNzRHWHpucktmOE5qS0FLTXNtTQ</guid><pubDate>Thu, 11 Mar 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5fZXU2SDR3cWxReG9rNGNuSGFITkNBMXdFZ2FhSmFPYm1UTW9WYzVKck1fYkhLMHRKNG43VXRZN2FxbnZmNzRHWHpucktmOE5qS0FLTXNtTQ?oc=5" target="_blank"&gt;엠디뮨-美엑소나노RNA, 표적 약물전달 공동연구 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>삼성바이오에피스-인투셀, ADC 공동연구 계약 체결 - 매경헬스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFB1M1p6ZG40R2NVLW95OEZIMU9tTGVFV2hYaXBqUUdTLXdoMGc4OTI1Z3piMU5OWXQ4eWxSbU5KRnQzRk1URDFfNUh4T1cxNU9BQ2xBalA2czVKVVBZNktOWUpudmlteTZXSzB5SQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFB1M1p6ZG40R2NVLW95OEZIMU9tTGVFV2hYaXBqUUdTLXdoMGc4OTI1Z3piMU5OWXQ4eWxSbU5KRnQzRk1URDFfNUh4T1cxNU9BQ2xBalA2czVKVVBZNktOWUpudmlteTZXSzB5SQ</guid><pubDate>Tue, 05 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB1M1p6ZG40R2NVLW95OEZIMU9tTGVFV2hYaXBqUUdTLXdoMGc4OTI1Z3piMU5OWXQ4eWxSbU5KRnQzRk1URDFfNUh4T1cxNU9BQ2xBalA2czVKVVBZNktOWUpudmlteTZXSzB5SQ?oc=5" target="_blank"&gt;삼성바이오에피스-인투셀, ADC 공동연구 계약 체결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매경헬스&lt;/font&gt;</description><source url="https://www.mkhealth.co.kr">매경헬스</source></item></channel></rss>